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The tocols (α-, β-, γ- and δ- tocopherols (T); α-, β-, γ- and δ-tocotrienols (T3)) make up the 
vitamin E family of antioxidants.  Tocols have many health benefits. γ-T3 has been shown to protect 
against harmful radiation effects in mice.  During rice bran oil refining up to 90% of tocols in rice bran are 
lost to the deodorizer distillate. The objective of this study was to optimize parameters for analyzing and 
isolating tocols from rice bran oil deodorizer distillate (RBODD).  NP-HPLC analysis of tocol standards 
was optimized by testing ten mobile phases.  Tocol extraction was optimized by testing three 
concentration solvents (acetonitrile, methanol, ethanol) using various solvent:RBODD ratios (5:1, 10:1, 
15:1, 20:1) at two temperatures (4°C, -20°C).  Hexane (HX)-ethyl acetate (EA)-acetic acid (AA) 
(97.3:1.8:0.9 v/v/v) provided baseline resolution of all eight tocols.  All interactions including 
solvent*ratio*temperature had a significant effect on tocol levels in the extracts (p<0.0001). Acetonitrile 
(10:1, 4°C) was the most efficient solvent with extracts containing 57.4 mg tocopherols/g concentrate and 
61.4 mg tocotrienols/g concentrate.  These conditions provided extracts with 1.55- and 1.34-fold higher 
tocopherols and 2.23- and 1.82-fold higher tocotrienols than extracts obtained with ethanol and methanol, 
respectively.  Tocol contents in acetonitrile and ethanol extracts were highest when incubated at 4°C, 
while tocol content in methanol extracts were highest at -20°C.  Under the conditions described above, 
tocopherol composition was 34.0% α-T, 3.4% β-T, 44.9% γ-T and 17.4% δ-T and tocotrienol composition 
was 25.5% α-T3, 72.8% γ-T3 and 1.7% δ-T3.  Flash chromatography may be used to isolate a fraction 
rich in γ-T3 with a minimal proportion of alpha isomers, which may interfere with radioprotective 
properties. Use of ~1% load size and silica sample cartridge provided acceptable tocol separation.  A 
mobile phase of 100% HX-EA-AA (97.3:1.8:0.9 v/v) gave a fraction with a concentration of 138.2 mg γ-
T3/g extract (47.0% purity).  This purity was significantly lower than the fraction obtained using a linear 
gradient of 0.8% EA-AA (99.1:0.9 v/v) added to HX-AA (99.1:0.9 v/v), which contained 96.5% γ-T3 (69.3 
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GENERAL INTRODUCTION  
Rice is a staple for more than half the world’s population, with consumption growing in the United 
States, Asia and Africa (USDA 2009).  Arkansas is the leading rice-growing state, producing 42% of total 
U.S. rice (NASS 2011).  The milling step of white rice production involves removal of the bran layer, which 
contains 18-22% oil (McCaskill and Orthoefer 1994).  Until recently, rice bran was considered a by-
product of rice milling and was primarily used as a supplemental source of protein and vitamins B and E 
in animal feeds.  The development of heat stabilization techniques has allowed rice bran to be available in 
other forms such as rice bran oil (Rice Knowledge Bank 2009).    
The oil component of rice bran is a rich source of the vitamin E compounds tocopherols and 
tocotrienols.  These compounds, collectively known as tocols, possess lipid-soluble antioxidant activity, 
and exist in nature in eight different isoforms: d-α-tocopherol (α-T), d-β-tocopherol (β-T), d-γ-tocopherol 
(γ-T), d-δ-tocopherol (δ-T), d-α-tocotrienol (α-T3), d-β-tocotrienol (β-T3), d-γ-tocotrienol (γ-T3) and d-δ-
tocotrienol (δ-T3) (Schauss 2008).  While α-tocopherol is the only vitamin E compound to meet human 
dietary vitamin E requirements (Moreau and Lampi 2012), the other tocols, especially tocotrienols, have 
recently become of major research interest due to their potential human health benefits (Traber and 
Atkinson 2007).  Up to 90% of the tocols in rice bran are lost to the deodorizer distillate during the refining 
process of rice bran oil production (Nicolosi and others 1994).  
The primary role of vitamin E in the body is its antioxidant activity or ability to scavenge free 
radicals and protect against oxidative stress (Eitenmiller and Lee 2004), which has been linked to a 
number of diseases, including cancer, cardiovascular disease, diabetes and neurodegenerative diseases 
(e.g. Alzheimer’s, Parkinson’s) (Cross 1987).  Tocols have also been shown to lower cholesterol by 
inhibiting its biosynthesis, have anti-carcinogenic and anti-tumor effects by inducing apoptosis and 
preventing proliferation in cancer cells and reduce the risk of other harmful disorders such as stroke, 
cardiovascular disease and diabetes (Sen and others 2006).    
It is of special importance due to the recent earthquake-induced nuclear situation at Fukushima 
and the rising threat of radiological terrorism that γ-T3 has the ability to act as a radiation countermeasure 
(Kumar and others 2008).  Several studies have been conducted that investigate the degree to which γ-
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T3 ameliorates radiation injury.  Treatment with γ-T3 in irradiated mice resulted in increased survival 
rates, improved hematopoietic recovery and reduced vascular oxidative stress caused by irradiation 
(Ghosh and others 2009; Berbée and others 2009, 2010, 2011b).  It has been suggested that δ-T3 may 
also provide some significant radioprotective potential (Li and others 2010).  Outside of emergency 
nuclear situations, the radioprotective effects of γ-T3 and δ-T3 may be useful in therapy for radiation 
treatments in cancer patients as well (Kumar and others 2008).  However, it has been proposed that α-T 
may interfere with the radioprotective and anti-carcinogenic effects of γ-T3 and δ-T3 (Qureshi and others 
2000a; Shibata and others 2010).   
Therefore, there exists a need to develop efficient extraction methods of health-promoting 
tocotrienols from rice bran oil deodorizer distillate, as well as analytical methods for the routine analysis of 
tocols.  In order to produce a fraction that can provide the radioprotective benefits of γ-T3, this compound 





















Objective 1:  To optimize analytical HPLC conditions for the baseline separation of all eight tocopherol 
and tocotrienol isomers. 
 
Objective 2:  To optimize the extraction of tocotrienols and tocopherols from rice bran oil deodorizer 
distillate.   
 
Objective 3:  To optimize flash chromatography conditions for isolating γ-tocotrienol from tocol-rich 























Rice at a Glance 
Rice Industry.  Rice is a staple for more than half the world’s population, with consumption 
growing in the United States, Asia and Africa (USDA 2009).  In fact, world consumption of milled rice has 
increased by 40% in the last 30 years, up from 61.5 kg per capita to 85.9 kg per capita (UNCTAD 2011).  
The top producers of milled rice are China, India and Indonesia, with United States being the tenth largest 
producer worldwide (USDAFAS 2012). 
In the United States, rice production is dominated by four different regions of the country:  
Arkansas Grand Prairie, Mississippi Delta, Gulf Coast and Sacramento Valley (USDA 2009).  Among the 
states in these regions, Arkansas is the largest rice-growing state producing 42% of total U.S. rice or 
79,118 hundredweight of the 188,069 hundredweight produced in 2011 in the U.S. (NASS 2011).  The 
U.S. rice industry produced all types of rice, including long-, medium- and short-grain cultivars, as well as 
aromatic and specialty varieties (USARF 2011b). 
Rice Physiology.  A mature rice kernel is made up of several parts (Figure 3.1).  The hull, which 
surrounds each whole grain of rice, is made up of very hard cellulose and fibrous tissues and is covered 
with abrasive glass-like spikes.  These physical characteristics allow the hull, also called the husk, to 
protect the grain during maturation against insects, microorganisms and moisture (Belsnio 1988).  
Underneath the hull is the bran layer, which is high in oil, vitamins and minerals (USARF 2011a).  The 
high oil content (18-22%) in rice bran makes it susceptible to oxidation, which leads to rancidity and 
overall deterioration in quality of the rice (Belsnio 1988; McCaskill and Orthoefer 1994).  The lipids found 
in rice bran are vulnerable to two types of deterioration:  hydrolytic and oxidative rancidity.  Hydrolytic 
rancidity is the type that primarily affects rice bran (McCaskill and Orthoefer 1994).  After removing the 
hull in the dehulling process, the rice is considered to be brown rice, a whole grain.  Brown rice can be 
further processed to produce white rice, which is made up of the starchy endosperm (germ) underneath 
the bran.  This processing step, called milling, employs pressure and abrasion between rice kernels to rub 
off the bran layer to produce white or “polished” rice.  Typically, the nutrients lost during milling are 
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replaced by “enriching” the rice, done by coating white rice with a thin layer of thiamine, niacin, iron and 
folic acid (USARF 2011a). 
 
Figure 3.1.  The anatomy of a rice kernel (USARF 2011a). 
 
 
Rice Bran and Rice Bran Oil.  As mentioned previously, rice bran is obtained by first dehulling 
rough rice to produce brown rice.  The brown rice is milled to remove the bran layer, resulting in white rice 
(de Deckere and Korver 1996).  Historically, the primary use of rice bran was as a supplemental source of 
protein and vitamins B and E in feeds for ruminants and poultry.  However, stabilization techniques have 
been developed, leading to new uses for rice bran, such as the production of rice bran oil for cooking 
(Rice Knowledge Bank 2009).  After milling, the rice bran undergoes an extraction process to produce 
rice bran oil (Figure 3.2) (Thai Edible Oil Group 2005).  Rice bran oil may find use as either industrial 
grade oil or edible oil.  Petroleum-based solvents are used to extract oil from rice bran for industrial uses 
(Roy and Chandra 1975).  To produce edible oil, the oil is extracted from rice bran by solvent extraction 
and/or hydraulic pressing.  Various solvents may be used in oil extraction, though hexane is the most 
commonly employed.  Solvent extraction may take place in a batch-type or continuous extractor (Nicolosi 
and others 1994).  Rice bran contains the enzyme lipase, which is activated by the rice polishing process.  
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This results in rapid hydrolysis of rice bran lipids and an increase in fatty free acid content, leading to 
rancidity.  In order to prevent high levels of free fatty acid formation, the lipase must be inactivated by 
heat immediately after milling (de Deckere and Korver 1996; Thai Edible Oil Group 2005).  The rice bran 
is stabilized by steaming, which thermally deactivates the lipase and also helps to free the oil from other 
bran components.  This treatment also assists in bran pellet formation, which provides shorter extraction 
times because it allows for higher solvent percolation.  The micella, which is the portion containing both 
solvent and oil, is usually filtered, dewaxed and refined before distillation of the solvent, referred to as 
desolventizing.  Oil extraction produces crude rice bran oil, as well as defatted bran, wax and soaps of 




Figure 3.2.  Process flow diagram of crude RBO production. 
 
 
Once the crude rice bran oil is obtained, it is refined to produce high quality rice bran oil, which 
contains 12% of the rice bran raw material (Thai Edible Oil Group 2005) (Figure 3.3).  During the refining 
process, the oil undergoes degumming, neutralization, bleaching, dewaxing, winterization and 
deodorization. The rice bran oil is degummed using agents such as phosphoric or citric acids to hydrolyze 
gums found in the oil, which are polar lipids with surface-active properties.  The oil is heated and 
hydrated, and the wet gums are separated by centrifugation.  The free fatty acids in the oil are then 
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neutralized with caustic soda (NaOH), which converts them to sodium soaps.  The soaps are hydrated 
and removed by centrifugation.  The oil is bleached to remove pigments, oxidized lipids and polar 
components.  This is done using acid-activated bleaching clays, which are removed after bleaching by 
filtration.  Dewaxing involves cooling the micella (15°C) to achieve crystallization and then removing the 
suspended waxes by either filtration or centrifugation.  Next, the oil is winterized to remove high melting 
triglycerides.  The oil is cooled further (5°C), and the crystallized glycerides are removed by filtration to 
produce stearine (high melting fraction) and oil (low melting fraction).  Deodorization is done as the last 
step to remove odors, flavors and free fatty acids from the oil fraction.  This is done by steam distillation, 
which uses high vacuum, steam purging and high-heat treatment (4-8 mmHg, 3-5% steam, 220-250°C) of 
the oil.  This process removes volatile compounds, including aldehydes, ketones and peroxides.  
Unsaponifiables, such as tocopherols, sterols and tocotrienols, are also removed from the oil, resulting in 
deodorizer distillate with a high level of these compounds.  Up to 90% of the oryzanol and tocotrienols 




Figure 3.3.  Process flow diagram for purified RBO and RBODD production.  
 
Rice bran contains several compounds that act as nutraceuticals, which are natural compounds 
that provide benefit beyond basic nutrition.  These compounds include the antioxidant oryzanol and the 




Vitamin E is the collective name for a family of eight major compounds that possess lipid-soluble 
antioxidant activity:  d-α-tocopherol, d-β-tocopherol, d-γ-tocopherol, d-δ-tocopherol, d-α-tocotrienol, d-β-
tocotrienol, d-γ-tocotrienol and d-δ-tocotrienol (Schauss 2008).  The vitamin was first discovered in 1922 
by Evans and Bishop, who found that supplementation with the then-unknown dietary factor was 
beneficial in reproductive studies with rats (Evans and Bishop 1922).  These researchers named the 
compound vitamin E, since vitamin D had recently been discovered (Eitenmiller and Lee 2004). 
 
Figure 3.4.  Structures of tocopherols and tocotrienols. 
 
The parent compound of the eight compounds is tocochromanol, or tocol (2-methyl-2-(4’,8’,12’-
trimethyltridecyl)-chroman-6-ol) (Eitenmiller and Lee 2004).  The main difference in structure between 
tocopherol and tocotrienol is the degree of saturation of their hydrophobic tails.  Tocopherol has a 
saturated phytyl tail, and tocotrienol has an unsaturated farnesyl isoprenoid tail (Schauss 2008).  α-, β-, γ- 
and δ-tocols are characterized by the number and position of methyl substituents on the aromatic ring 










Trivial and Chemical Names of the Tocopherols and Tocotrienols 
Trivial name Chemical name Abbreviation 
Tocopherol 2-methyl-2-(4’,8’,12’-trimethyltridecyl)chroman-6-ol  
α-tocopherol 5,7,8-trimethyltocol α-T 
β-tocopherol 5,8-dimethyltocol β-T 
γ-tocopherol 7,8-dimethyltocol γ-T 
δ-tocopherol 8-methyltocol δ-T 
Tocotrienol 2-methyl-2-(4’,8’,12’-trimethyltrideca-3’,7’,11’-trienyl)chroman-6-ol  
α-tocotrienol 5,7,8-trimethyltocotrienol α-T3 
β-tocotrienol 5,8-dimethyltocotrienol β-T3 
γ-tocotrienol 7,8-dimethyltocotrienol γ-T3 
δ-tocotrienol 8-methyltocotrienol δ-T3 
(Eitenmiller and Lee 2004) 
 
Tocopherol has three asymmetric carbons (2, 4’ and 8’), and only RRR-tocopherols are found in 
nature.  Synthetic tocopherols (all-rac-tocopherol), produced by condensing isophytol with tri-, di- or 
monomethyl hydroquinone, are equimolar racemic mixture of eight stereoisomers (Ghosh and others 
2008).  Tocotrienol has only one chiral center at carbon 2, and so only 2D and 2L stereoisomers are 
possible.  Because of the double bonds in the phytyl tail, there are four cis/trans geometric isomers.   
Only the 2R, 3’-trans, 7’-trans isomers exists in nature (Eitenmiller and Lee 2004). 
There are two tocotrienols that have been recently discovered:  desmethyl tocotrienol [3,4-
dihydro-2-methyl-2-(4,8,12-trimethyltrideca-3’(E),7’(E),11’-trienyl)-2H-1-benzopyran-6-ol] and didesmethyl 
tocotrienol [3,4-dihydro-2-(4,8,12-trimethyltrideca-3’(E),7’(E),11’-trienyl)-2H-1-benzopyran-6-ol].  These 
compounds were isolated from stabilized and heated rice bran.  They exhibit similar hypocholesterolemic 
properties as known tocotrienols, though their antioxidant and antitumor properties may be greater 
(Qureshi and others 2000a). 
α-T is the only vitamin E compound to meet human dietary vitamin E requirements.  While all 
tocols are equally absorbed, α-T is preferentially retained by hepatic α-tocopherol transfer protein (α-TTP) 
(DellaPanna 2005).  Although the body prefers α-T, all of the naturally occurring vitamin E forms are 
thought to have similar antioxidant activities.  The other tocols, especially tocotrienols, have recently 
become the subject of research regarding their relevance to human health (Traber and Atkinson 2007).  
γ-T3 and δ-T3 have been found to have potent anticancer, hypocholesterolemic and antioxidant 
properties, as well as radioprotective effects (Schauss 2008).   
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Vitamin E is not synthesized by the human body and must be obtained from the diet.  α-T is the 
main form present in nearly all green plant tissues and animal products, though tocotrienols are found in 
abundance in edible oils originating from plants (Gregory 2008; Zielinski 2008).  Rice bran oil and palm 
oil, for instance, are very rich sources of tocotrienols.  In human nutrition, both tocopherols and 
tocotrienols are obtained primarily from cereal grains such as oat, barley, rye, wheat, corn and rice 
(Zielinski 2008).  Deodorization of rice bran oil and palm oil results in a high level of tocotrienols in the 
deodorizer distillate, up to 1% vitamin E by weight.  Vitamin E is also available commercially, as pure 
standards, oils and concentrates, powders, gelatin microcapsules and water-soluble vitamin E 
supplements (Eitenmiller and Lee 2004). 
Vitamin E deficiency is rarely due to dietary insufficiency.  Typically, a deficiency results from 
genetic abnormalities in α-TTP, fat malabsorption syndromes or protein-energy malnutrition.  Vitamin E 
deficiency affects the central nervous system, with symptoms including peripheral neuropathy, 
spinocerebral ataxia, skeletal myopathy and pigmented retinopathy (Institute of Medicine 2000).   
The primary role of vitamin E in the body is its antioxidant activity.  Vitamin E scavenges free 
radicals and defends against cellular damage they impart.  α-T modulates cell signaling by inhibiting 
protein kinase C (PKC).  This results in protection against inflammation and atherosclerosis, regulation of 
cell proliferation, enhancement of immune response and regulation of free radical production.  It is 
believed that α-T also regulates gene expression at the transcriptional stage (Eitenmiller and Lee 2004).  
Tocotrienols have been shown to lower cholesterol and protect against cancer and other diseases.  
These beneficial effects are discussed in detail in the “Health Benefits of Rice Bran and Tocols” section of 
this review. 
Chemical syntheses of all four tocotrienol isomers have been achieved, but the process yields 
inactive l isomers in addition to the active d isomers (Qureshi and others 2000a).  Some research 
suggests that chemically synthesized γ-T3 and δ-T3 purified from natural sources have identical 
biological activities (Wright and others 1990).  However, the bioavailability of synthetic α-T was shown to 




Sample Preparation for Chromatography Analysis 
Tocols are lipid soluble and are readily soluble in organic solvents.  Thus, extraction of 
tocopherols and tocotrienols is usually performed by direct solvent extraction.  A common approach for 
oils containing high levels of vitamin E is to dilute the oil with solvent before HPLC analysis.  If the oil is 
sparingly soluble, sample cleanup procedures must be done (Eitenmiller and Lee 2004).  The solvent 
used for extraction must be able to liberate tocols from lipophilic membranes and to reach tocols within 
the water phase.  When tocols are to be extracted from cereal grains or processed foods, saponification 
(alkaline hydrolysis) may be employed to break down interactions between tocols and other compounds 
like carbohydrates and proteins (Moreau and Lampi 2012).  With both direct and saponification extraction 
methods, dehydration by use of disodium sulfate is a critical post-extraction step in order to ensure 
stability of the lipophilic tocols (Lee and others 2003).  Also, extraction conditions should be controlled in 
order to prevent oxidation.  It is recommended to work under subdued lighting, low temperature and in an 
inert atmosphere (Moreau and Lampi 2012). 
Solvent Extraction.  Solvent extraction is the simplest preparation method, as it requires only 
evaporation of the solvent and dissolving the residue in the mobile phase (Moreau and Lampi 2012).  
Extraction of tocopherols and tocotrienols from a simple matrix such as oil is possible by diluting the 
sample with hexane or mobile phase and directly injecting onto a normal-phase column (Eitenmiller and 
Lee 2004). Extra steps may be needed depending on the type of sample.  When extracting tocols from 
plasma, deproteinization with ethanol may be done first to facilitate extraction (Lee and others 2003).  Oil 
seeds and other solid samples should be ground to a fine, homogenous powder to enhance tocol 
extractability (Leo and others 2005).  Soxhlet extraction has been shown to be a highly reproducible and 
efficient method for extracting tocopherols from soybeans.  This method yielded higher recovery values 
(94-110%) of tocopherol homologs than saponification and direct solvent extraction methods (Lim and 
others 2007).  The Folch method is another typical solvent extraction procedure.  Both the Soxhlet and 
Folch methods require more time and solvent and are therefore less than ideal (Fratianni and others 
2002).  Common solvents used for tocol extraction include hexane (Shin and Godber 1994; Kramer and 
others 1997; Ryynänen and others 2004; Sundl and others 2007; Heinemann and others 2008), diethyl 
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ether (Verleyen and others 2001; Ko and others 2008), ethanol (Ito and others 2005) and solvent 
mixtures such as hexane-ethyl acetate (Abidi 2003; Panfili and others 2003), heptane-ethyl acetate 
(Lampi and others 2008), hexane-butylated hydroxytoluene (BHT) (Lee and others 2000) and heptane-
diethyl ether (Schwartz and others 2008).   
Alkaline Hydrolysis Assisted Extraction.  Alkaline hydrolysis, or saponification, uses KOH to 
improve the extractability of tocols.  This step has many purposes, including destruction of protein, lipid 
and carbohydrate complexes; hydrolysis of triacylglycerols, phospholipids, and tocopherol and tocotrienol 
esters; removal of pigments or other interfering substances; and facilitation of vitamin E extraction by 
disrupting the sample matrix.  All of these effects enhance the extractability of tocols within the food 
matrix (Eitenmiller and Lee 2004).  Alkaline hydrolysis is more commonly needed with reversed-phase 
HPLC analysis, since co-extracting neutral lipids do not interfere in normal-phase chromatography.  In 
high-fat samples, though, it may be beneficial to remove lipids by saponification to prevent interference in 
normal-phase chromatographic analysis (Kramer and others 1997).  Several studies have suggested that 
saponification is needed for solvent extraction of tocols, in order to transform the lipid esters into their 
corresponding alcohols (Fratianni and others 2002; Panfili and others 2003; Ryynänen and others 2004).  
A method to extract vitamin E from broccoli and tomato was optimized using response surface 
methodology (RSM) in 2000 (Lee and others 2000).  The researchers determined optimal saponification 
conditions were a sample size of 7.5 g saponified by 8.4-8.9 ml of 60% KOH for 50.7-54.3 minutes at 
70°C with 30.1-35.0% ethanol and confirmed the conditions by ridge analysis.  While this method is 
specific to vitamin E extraction in tomato and broccoli, the study shows that the RSM technique may be 
helpful in optimizing saponification-assisted extraction parameters for other sources.  Typically an 
antioxidant such as BHT, pyrogallol or ascorbic acid is added to the saponification mixture to avoid 
oxidation of the analyte (Kramer and others 1997; Fratianni and others 2002; Abidi 2003; Lee and others 
2003; Panfili and others 2003; Ryynänen and others 2004; Schwartz and others 2008).   
Alternative Extraction Methods.  There are several alternatives to the traditional solvent extraction 
methods for tocol analysis.  Supercritical fluid extraction (SFE) is an environmentally friendly technique 
that uses little or no solvents.  Extraction parameters (temperature, fluid density) are easily optimized and 
managed, and extraction is relatively fast (Moreau and Lampi 2012).  Although recoveries of tocols may 
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not be as high with SFE compared to the Soxhlet and Folch extraction methods, the benefits of SFE, e.g. 
little manipulation of sample, less degradation of vitamins and reduction in time and solvents, may 
outweigh the lower tocol recoveries (Fratianni and others 2002).  Another method to reduce the labor-
intensive preparation for tocol analysis is pressurized liquid extraction (PLE), also known as accelerated 
solvent extraction (ASE).  PLE of residue oil from pressed palm fiber (PPF) samples yielded higher 
concentrations of α-T3 and γ-T3 compared to those obtained by using Soxhlet extraction.  In the same 
study, the researchers observed a 4-fold reduction in solvent consumption and a 16-fold reduction in 
extraction time with PLE compared to the Soxhlet method (Sanagi and others 2005).  Solid-phase 
extraction (SPE) has recently been applied to concentrate tocols from extracts and has many potential 
applications.  In fact, SPE is now one of the more preferred extraction methods for fractionation of a tocol-
rich fraction (Moreau and Lampi 2012).  Virgin olive oil α-T was concentrated by silica cartridge SPE, with 
α-T first being retained in the cartridge and then being eluted with hexane/diethyl ether (99:1 v/v) 
(Grigoriadou and others 2007).  Molecularly imprinted (MI) polymers were synthesized to selectively 
extract and purify α-T from crushed vegetable samples using SPE (Puoci and others 2007).  
Extraction of Tocols from Deodorizer Distillate.  A recent study aimed to concentrate the tocols 
present in RBODD, finding that treatment with acetonitrile yielded a tocol concentration of 85.0 mg/g, 
which was significantly higher than any other solvent tested, including methanol (51.6 mg/g), ethanol 
(37.1 mg/g) and hexane (34.9 mg/g).  These researchers cooled tocol concentrates to -20°C to crystallize 
and remove sterols, and used saponification and extraction with diethyl ether to prepare the tocol extracts 
for HPLC analysis (Ko and others 2008).  Soybean oil deodorizer distillate (SODD) is a good source of 
tocopherols and phytosterols.  SODD was chemically treated by saponification with potassium hydroxide 
at 65°C to release conjugated fatty acids from acylglyercol molecules.  Then, molecular distillation was 
done to remove the free fatty acids (FFAs) and fatty acids of acylglycerols.  The tocopherols were then 
extracted from the residue using ethanol-water (90:10 v/v) (Ito and others 2005). 
Isolation of Tocols using Flash Chromatography.  Flash chromatography is commonly used for 
laboratory-scale purification of synthetic compounds, fractionation of complex mixtures, and isolation of 
compounds from natural sources.  This type of chromatographic technique uses short columns with 
solvent flow accelerated by application of modest pressure.  The columns are typically packed with 
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particles of intermediate size (40-63 µm) and may be applied for both reversed-phase and normal-phase 
separations.  While resolution may be decreased with flash chromatography compared to HPLC, 
operational costs are lower and compounds may be recovered in higher purity (Poole 2003).  Qureshi and 
others (2000a) utilized flash chromatography to prepare 95% or greater pure fractions of α-T, α-T3, β-T3, 
γ-T3, and a δ-T/δ-T3 mixture from rice bran using a silica column and an elution gradient of hexane with 
increasing amounts of diethyl ether.  These researchers have used this flash chromatography method for 
isolating large quantities (~9 g) of tocotrienol-rich fraction from rice bran for use in cholesterol studies 
(Qureshi and others 2000b, 2001b, 2002; Qureshi and Peterson 2001).  Wan and others (2008) used a 
low-pressure column chromatography system to purify individual tocopherol isomers from SODD.  The 
researchers tested the effects of eluent, flow rate and load size on separation efficiency.  Under optimal 
conditions, α-, γ- and δ-tocopherols were isolated at 92.35%, 91.23% and 89.95% purity, respectively, 
with very little sample preparation.  Cyclohexane and ethanol were used in varying volume ratios.   
Chromatography Analysis Methods  
Many chromatographic techniques can be used for characterization of lipid antioxidants, such as 
column chromatography, thin layer chromatography (TLC), gas chromatography (GC), normal- and 
reversed-phase HPLC, among others.  TLC and column chromatography are the least expensive 
techniques, though they offer only rough estimates of the antioxidants in samples (Abidi 2000).  Prior to 
the 1990s, GC was thought to be the most precise method for vitamin E analysis.  GC techniques have 
become less routinely used with the increased popularity of HPLC methods.  However, GC still sees use 
when identifying tocopherols and tocotrienols in complex matrices.  Tocols are usually analyzed as their 
ester or trimethysilyl derivatives to improve volatility (Moreau and Lampi 2012).  Based on the literature, 
the majority of researchers prefer normal-phase HPLC methods for tocol analysis (Kamal-Eldin and 
others 2000; Panfili and others 2003; Ryynänen and others 2004). Kamal-Eldin and co-workers (2000) 
were able to achieve baseline separation of all four tocopherols and all four tocotrienols using a diol-
bonded silica column (250 mm × 4 mm) with an isocratic mobile phase of hexane-methyl-tert-butyl ether 
(MTBE) (96:4 v/v) (2 ml min-1) (Figure 3.5).  A previous study (Shin and Godber 1994) was able to isolate 
all eight isomers with normal-phase semi-preparative HPLC, using a silica column with a mobile phase of 
hexane-ethyl acetate-acetic acid (97.3:1.8:0.9 v/v/v) (3 ml min-1).  Similar separation using the same 
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column and mobile phase was achieved more recently (Fratianni and others 2002; Panfili and others 
2003).   
 
 
Figure 3.5.  Normal-phase baseline separation of Ts and T3s with a diol column and a mobile phase of 
hexane-MTBE (96:4 v/v) (Kamal-Eldin and others 2000). 
 
Stationary and Mobile Phases.  Although reversed-phase columns are generally known to be 
more stable and more durable than normal-phase columns, most cannot separate the beta and gamma 
isomers of tocopherols and tocotrienols (Kramer and others 1997; Abidi 1999).  However, it was possible 
to separate all tocol isomers with RP-HPLC using a non-silica octadecanoyl polyvinyl alcohol (ODPVA) 
column and a polar pentafluorophenylsilica column (Abidi 1999, 2003).  Because normal-phase columns 
are able to separate all tocol isomers, including the beta and gamma isomers, and are more selective for 
fat-soluble vitamins, most researchers rely heavily on normal-phase techniques for tocol analysis (Kamal-
Eldin and others 2000).  Also, normal-phase silica-based columns allow for direct injection of oil in the 
case of vitamin E analysis in fats and oils.  If the sample contains large amounts of polar lipids, however, 
they may precipitate out of the nonpolar mobile phase (Eitenmiller and Lee 2004).  Most researchers use 
polar silica columns for separation of mixed tocol samples, such as LiChrosorb Si 60 (Kamal-Eldin and 
others 2000; Lee and others 2000; Ko and others 2008) and Supelcosil LC-Si (5 µm) (Shin and Godber 
1994; Heinemann and others 2008).  Silica may be modified by adding moieties to form new stationary 
phases, such as diol-bonded silica, which is slightly less polar than non-bonded silica (Abidi 2000).  Diol-
bonded columns have been employed in several studies for normal-phase separation of tocols (Kramer 
and others 1997; Kamal-Eldin and others 2000; Moreau 2006; Moreau and others 2007).   
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Most normal-phase mobile phases are hexane-based binary systems, with organic modifiers such 
as tetrahydrofuran (Moreau and others 2007), methyl-tert-butyl-ether (Abidi 2000; Moreau 2006), 
isopropanol (Tan and Brzuskiewicz 1988; Kramer and others 1997; Lee and others 2000; Ito and others 
2005; Lim and others 2007; Peterson and others 2007; Ko and others 2008) and dioxane (Ryynänen and 
others 2004; Amaral and others 2005; Sanagi and others 2005; Sundl and others 2007).  A heptane-
based mobile phase with 3% 1,4-dioxane (by volume) was used in some studies (Lampi and others 2008; 
Schwartz and others 2008).  Ternary systems have also been effective mobile phases, such as hexane-
ethyl acetate-acetic acid (Frattiani and others 2002; Panfili and others 2003; Heinemann and others 
2008).  Kamal-Eldin and others (2000) compared chromatographic tocol analysis across several different 
column and mobile phase combinations, and it was found that hexane-1,4-dioxane and hexane-MTBE 
provided the best separation.  Gradient techniques may be applied in instances of complex matrices 
(Abidi 2000).  For example, Shin and Godber (1994) isolated the eight tocol isomers using a gradient of 0-
15% tetrahydrofuran (THF) in hexane on a semi-preparative HPLC system.   
Elution Characteristics.  It has been well established that with normal-phase chromatography, the 
eight vitamin E homologues elute in order of increasing polarity:  α-T→α-T3→β-T→γ-T→β-T3→γ-T3→δ-
T→δ-T3 (Abidi 2000).  The elution order indicates that the polarity of the tocols decreases as the number 
of methyl groups increases (Tan and Brzuskiewicz 1989).  It is important to note that shorter HPLC run 
times provide larger analyte resolution (Abidi 2003).    
Detection Methods.  Tocols can be detected using ultraviolet (UV), fluorescence (FLD), 
electrochemical (EC) or evaporative light scattering (ELSD) detectors (Eitenmiller and Lee 2004).  In 
terms of sensitivity, these types of detectors follow this trend:  EC>FLD>UV>ELSD (Abidi 2000). The 
most commonly used detector for vitamin E is FLD, while ELSD has been shown to be especially 
effective when analyzing tocols in blood and serum samples, and tocols that were resolved by RP-HPLC.  
The enhanced sensitivity of FLD over UV is due to the fact that two wavelengths are used compared to 
one (280 nm) for UV detection.  The chromanol ring structure of tocols has fluorescence properties of 
maximal excitation at 294 nm and emission at 326 nm (Moreau and Lampi 2012).  Also, antioxidants used 
to protect analytes from oxidation may cause background interference with UV detection, as was seen 
with ascorbic acid (Lee and others 2003).  ELSD is much less sensitive than the other detectors and is 
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not used much due to high operating cost and instrument complexity (Eitenmiller and Lee 2004).  Cunha 
and others (2006) found that the connection of a diode array detector (DAD) with FLD provided more 
information from one analysis of the tocols in olive oil than the use of a UV or ELSD.  However, when 
tocols were analyzed by both FLD and a charged aerosol detector (CAD), it was observed that the CAD 
was less sensitive and gave a chromatogram with several large, unidentified peaks (Moreau 2006).  
HPLC methods interfaced with mass spectrometry (MS) allow for simultaneous separations and 
quantification (Abidi 2000).  RP-HPLC coupled with MS analysis of tocopherols was found to be a fast, 
selective, sensitive and accurate method for the determination of the four tocopherol homologues in 
sunflower oil and milk (Lanina and others 2007). 
Traditional Nonchromatography Analysis Methods   
Before chromatography methods became popular, a spectrophotometric method was used to 
measure total tocopherols.  The original technique involved ferric chloride with absorbance measurement 
at 520 nm (Rawlings 1944).  Fourier transform infrared (FTIR) spectroscopy been used for analysis of 
vitamin E in canola, flax, soybean and sunflower oils (Ahmed and others 2005).  A rapid FTIR method has 
been developed to quantify α-T in vegetable oils (Silva and others 2008). 
Health Benefits of Rice Bran and Tocols 
Radioprotective Effects 
Ionizing Radiation Exposure.  Exposure to ionizing radiation, whether during emergency nuclear 
situations or during cancer radiotherapy treatment, may cause significant injury to human tissues.  For 
many years, there has been threat of a terroristic attack using nuclear/radiological methods.  Nuclear 
terrorism has become the less likely option because radiological dispersion devices (RDDs or “dirty 
bombs”) can be more readily made and used for radiological terrorism.  The threat takes a variety of 
forms from detonation of RDDs to attacks on nuclear power plants and other nuclear facilities (Kumar and 
others 2008).  As menacing as the potential for a terroristic radiological attack may be, each day many 
people experience the harmful effects of radiation as they undergo therapy to eradicate cancer.  Around 
one million people in the United States turn to radiotherapy as cancer treatment each year (NCCN n.d.).  
There is also the risk of large-scale accidental exposure to radiation at nuclear power plants.  Situations 
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may arise like the 2011 earthquake-induced incident at Fukushima or the Chernobyl accident in 1986, 
which resulted in mass exposure to people living near or working in the facilities (Berbée 2011). 
Effects of Radiation.  Whether exposure occurs during clinical or non-clinical situations, radiation 
can cause serious damage to body cells in several ways.  Hematopoietic syndrome, which occurs at 
radiation doses of 1 to 6 Gy, occurs when radiation targets cells in the bone marrow, spleen and lymph 
nodes.  Because these are the primary sites of blood cell production (hematopoiesis), hematopoietic 
syndrome results in the depletion of red blood cells, white blood cells and platelets, leading to severe 
sensitivity to infections and the increased possibility of hemorrhagic complications.  Gastrointestinal (GI) 
syndrome occurs after exposure to 6 Gy or more of radiation, and affects the cells lining the digestive 
tract.  Symptoms include loss of appetite, severe diarrhea, luminal hemorrhage, massive loss of fluids 
and electrolytes, dehydration, infection and death.  Survival from GI syndrome is very unlikely.  Even with 
advanced medical attention and support, only about 50% of people with GI syndrome survive (Bushberg 
2009).  Radiation in high doses (>20-30 Gy) causes damage to the central nervous system (CNS), 
inducing what is known as CNS syndrome.  This degree of radiation causes death within a few days of 
exposure.  The specific mechanism of death, though not fully understood, may result from a variety of 
CNS effects, such as neurologic and cardiovascular breakdown as well as hematopoietic and GI 
symptoms (Kumar and others 2008).   
The development of preventive or protective measures against harmful radiation effects is of vital 
importance.  Because of the differing types of radiation exposure, the radioprotectant must be applicable 
whether administered before or during exposure.  It also must be nontoxic for all populations even at high 
doses, easily administered, fast acting, effective, stable, as well as simple, inexpensive and easy to store 
(Kumar and others 2008). 
Mechanisms of Radiation Injury.  Radiation affects molecules within body tissues through either 
direct or indirect action, both of which produce free radicals.  Biomolecules such as DNA, enzymes and 
plasma and nuclear membrane constituents are affected directly through excitation and ionization, while 
an indirect reaction occurs between radiation and water in the system.  These types of reactions produce 
the following free radicals, in order of highest to lowest toxicity:  hydroxyl radical (OH∙), superoxide (O2∙-) 
and hydrogen peroxide (H2O2) (Kumar and others 2008). 
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Direct reaction Radiation + TH (target biomolecule) ! T (target free radical) + H+ + e- 
Indirect reaction Radiation + H2O + e- ! H2O+ + e- 
 H2O + e- ! H∙ + OH∙ (hydroxyl radical) 
Also H2O + e- ! eaq- (hydrated electron) 
 eaq- + O2 ! O2∙- (superoxide) 
A series of interdependent reactions occurs post-irradiation to cause endothelial dysfunction.  As 
a result of the radiation-induced free radical production, cells go into a state of oxidative stress.  This 
results in the rapid oxidation of BH4 (5,6,7,8-tetrahydrobiopterin), a critical cofactor for endothelial nitric 
oxide synthase (eNOS) enzymes, to 7,8-dihydrobiopterin (BH2).  Nitric oxide (NO) is diminished as it 
reacts with the superoxide radical to produce toxic peroxynitrite (OONO-), a potent inducer of cell death 
(Kumar and others 2008; Berbée and others 2010).  A combination between the depletion of BH4 and the 
increasing production of peroxynitrite contribute to the oxidation of BH4, leading to eNOS uncoupling, 
which results in further superoxide and peroxynitrite production at the cost of NO.  These biological 
cellular changes cause dysfunction of NO synthase, followed by vascular endothelial dysfunction, which 
has been linked to diabetes, hypertension, arteriosclerosis and other diseases (Berbée and others 2010).  
The presence of peroxynitrite results in many biological actions with harmful consequences, such as 
neurodegeneration, diminished ability of cells to protect against oxidant and free-radical damage, reduced 
anti-inflammatory ability, Lewy body formation (through protein aggregation), among others (Szabó and 
others 2007).  Ultimately, the harmful effects of radiation may result from a combination of reactions 
caused by the introduction of radiation to the biological system, beginning with increased oxidative stress 
and malfunctioning eNOS (Berbée and others 2010). 
Tocols as Radiation Countermeasures.  For many years, tocols have been considered attractive 
candidates for protection against negative radiation effects due to their antioxidant activities and lack of 
performance-degrading toxicity.  More recently, γ-T3 has become the focus of research as a nutraceutical 
with immense potential to be a radio-prophylactic agent.  Numerous studies have been done on α-T and 
its derivatives as a radiation countermeasure (Bichay and Roy 1986; Srinivasan and Weiss 1992; 
Felemovicius and others 1995; Mutlu-Türkoğlu and others 2000; Kumar and others 2002; Singh and 
others 2010).  δ-T3 may also have some significant radioprotective potential.  Li and others (2010) found 
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δ-T3 to protect 100% of total body irradiated (TBI) mice after 30 days.  A single dose of δ-T3 increased 
mouse bone marrow recovery as well as human hematopoietic stem and progenitor cell proliferation post-
TBI.  Current research suggests that γ-T3 may be a more potent radioprotectant than α-T due to 
suggested higher antioxidant activity.  Because of this, γ-T3 and its radioprotective properties have 
become a high-priority focus in recent studies. 
Gamma-Tocotrienol as a Radioprotectant.  A research group led by Berbée has published 
several recent studies reporting the degree to which γ-T3 ameliorates radiation injury and the proposed 
mechanisms involved.  In a 2009 study, Berbée and others found that survival rates at 30 days post-TBI 
of irradiated mice were increased from 0% to 88% when treated with 400 mg/kg γ-T3 twenty-four hours 
prior to total body irradiation (TBI).  Median survival time also significantly increased from 11.5 to 30 days 
(p=0.0001).  This confirms the same findings of another study the same year (Ghosh and others 2009).  
As radiation dose increases, so does severity of symptoms.  Berbée and others (2011b) found that γ-T3 
only significantly improved survival rate in mice irradiated at 10.5 and 11.5 Gy, but mortality was 
increased at 12.5 Gy.  Structural injury to the intestines was less in γ-T3-treated mice, and increased 
recovery of mucosal surface area after irradiation was observed.  γ-T3 treatment also caused improved 
survival of crypt colony cells (tissue stem cells of the intestinal mucosa) (Berbée and others 2009, 2011b).  
Increased hematopoietic recovery was seen in γ-T3-treated mice, with significantly higher counts of 
leukocytes, erythrocytes and platelets (p=0.01, p=0.01, p=0.01) at 14 days post-TBI compared to vehicle-
treated mice (Berbée and others 2009).  Hematopoietic toxicity was also significantly reduced in the study 
by Ghosh and others (2009).  Spleen colonies 12 days after 8.5 Gy irradiation were significantly higher in 
γ-T3 mice (p=0.0008) (Berbée and others 2009).  Research by Kulkarni and others (2010) provides 
evidence that γ-T3 protects bone marrow stem and progenitor cells in irradiated mice.  Hence, the effect 
of γ-T3 on hematopoietic recovery after radiation may be dependent upon its ability to preserve 
hematopoietic tissue.  In addition, γ-T3 attenuated immune system dysfunction and reduced vascular 
oxidative stress.  A single dose of γ-T3 protected against vascular peroxynitrite production 3.5 days 
(p=0.004) post-TBI  (Berbée and others 2009, 2010).  A later study also found γ-T3 to reduce 
peroxynitrite production (Berbée and others 2011b).  
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Mechanisms of Gamma-Tocotrienol Radioprotective Properties.  The exact mechanisms 
underlying the radioprotective effects of γ-T3 have not yet been determined, though it may be through 
many means.  It is thought that HMG-CoA reductase inhibition plays a role in γ-T3 radioprotection.  Unlike 
statins, which directly inhibit HMG-CoA reductase, both γ-T3 and δ-T3 mimic sterols in that they stimulate 
ubiquitination and degradation or HMG-CoA reductase by mediating the formation of the reductase-Insig 
complex.  γ-T3 was found to be more selective compared to δ-T3 (Song and others 2006).  Several in 
vivo (Pearce and others 1992; Qureshi and others 1986, 2000b) and in vitro (Parker and others 1993) 
studies have found that γ-T3 supplementation reduces HMG-CoA reductase activity by post-
transcriptional actions.  Berbée and others (2009) provide evidence that γ-T3 decreases radiation-
induced vascular oxidative stress through the inhibition (degradation) of HMG-CoA reductase.  In mice, γ-
T3 offered significant protection against peroxynitrite production (p=0.004), which was reversed by 
mevalonate treatment.  The literature shows that γ-T3 restores the bioavailability of BH4 by reducing the 
expression of GFRP (guanosine triphosphate cyclohydrolase 1 (GTPCH) feedback regulatory protein), a 
key regulatory protein in BH4 metabolism.  However, the decrease in expression was reversed by 
mevalonate with γ-T3, which suggests that this effect depends on the inhibition of HMG-CoA reductase 
activity (Berbée and others 2010).   
The radioprotective effects of γ-T3 may stem from its potency in inducing transcriptional gene 
expression changes.  γ-T3 effectively modified the expression of 898 genes, which corresponded to 233 
biological processes, including response to oxidative stress, response to DNA damage stimuli, regulation 
of cell death, regulation of cell proliferation, regulation of inflammatory response, hematopoiesis, blood 
vessel development and others, which are related to the cellular response to radiation.  α-T and γ-T only 
had effects on 39 and 172 genes, respectively, which may provide insight as to the mechanism by which 
γ-T3 is a more potent radioprotective countermeasure (Berbée and others 2011a). 
The antioxidant power of γ-T3 may also be partly responsible for its radioprotective effects.  The 
peroxynitrite produced during radiation-induced uncoupling is a reactive nitrogen species (RNS).  γ-T3 is 
a more efficient RNS scavenger than α-T, so it can be surmised that γ-T3 is a more effective 
radioprotectant.  This was seen in a side-by-side comparison at the Armed Forces Radiobiology 
Research Institute (AFRRI), where mice were injected with a 400 mg/kg dose of either α-T or γ-T3 twenty-
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four hours prior to 11 Gy of TBI.  None of the control mice or mice given α-T survived, while a survival 
rate of 40% was seen in mice given γ-T3 (Kumar and others 2008).  This may be because intestinal 
epithelial cells absorb γ-T3 faster than α-T (Tsuzuki and others 2007).  However, it may also be because 
γ-T3 is a more potent antioxidant than α-T (Qureshi and others 2000a).  It may be a combination of its 
antioxidant activity and its ability to protect against vascular, hematopoietic and GI injury that makes γ-T3 
such a strong radioprotectant.  
Potential for Synergistic Effects Between Gamma-Tocotrienol and Other Agents.  Combination 
therapy may have great potential in enhancing the radioprotective effects of γ-T3.  Pentoxifylline (PTX) is 
a phosphodiesterase inhibitor that exhibits antioxidant, immunomodulatory and vascular properties 
(Kumar and others 2008).  It has also been shown to be effective in treating some radiation-induced side 
effects alone (Okunieff and others 2004) and when combined with vitamin E (Delanian and others 2003; 
Boerma and others 2008).  When PTX was injected along with γ-T3 into mice before irradiation, 100% 
survival was observed after 30 days in mice exposed to 10.5, 11.5 and 12.5 Gy irradiation.  Lethality was 
decreased in the γ-T3 only groups, but only in mice exposed to 10.5 and 11.5 Gy TBI.  Spleen colony 
counts were significantly higher when PTX was used in addition to γ-T3.  While combination treatment did 
not affect leukocyte and erythrocyte levels, platelet recovery at day 14 was improved compared to 
treatment with γ-T3.  This suggests that combination treatment may be a viable way to enhance survival 
post-irradiation possibly by means of improved hematopoietic recovery (Berbée and others 2011b).  
Potentially, the somatostatin analog SOM230 (Pasireotide) and γ-T3 could be combined to reduce 
intestinal injury to a greater degree by acting through different mechanisms.  SOM230 has been shown to 
ameliorate intestinal injury by reducing exocrine pancreatic secretion (Fu and others 2009), while γ-T3 
improves crypt cell survival (Berbée and others 2009, 2011b).   
Antioxidant Activity 
Lipid Oxidation and Oxidative Stress.  Oxidation plays a role in biological systems as well as food 
products.  Oxidative stress occurs in the body when there is an imbalance between the generation and 
removal of reactive oxygen species (ROS).  In vivo ROS, such as free radicals (hydroxyl, peroxyl, 
superoxide radicals), as well as reactive non-radical oxygen species (hydrogen peroxide), may be created 
by naturally occurring endogenous processes (mitochondrial electron transport, defense phagocytes), as 
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well as exogenous sources (ionizing radiation from the sun, environmental pollutants, changed 
atmospheric conditions) and lifestyle stressors (smoking, alcohol consumption) (Ho and others 2008).  As 
mentioned previously, radiotherapy for cancer also greatly increases oxidative stress (Kumar and others 
2008; Berbée and others 2010).  In food products, any lipids present may undergo oxidation during 
storage.  Not only does lipid oxidation lead to food deterioration, nutrient loss, undesirable flavors and 
odors, and overall decreases in palatability, shelf-life and consumer acceptance (McClements and Decker 
2008), but it is also thought that ingestion of oxidized lipids may promote oxidative stress (Eitenmiller and 
Lee 2004).  Increased oxidative stress due to the overproduction of ROS has been linked to many 
diseases, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases (e.g. 
Alzheimer’s, Parkinson’s) and immune diseases, as well as the aging process (Cross 1987). 
Mechanisms of Oxidation and Vitamin E Antioxidant Activity.   Lipid oxidation, also called 
autooxidation, occurs in three steps:  initiation, propagation, and termination. 
Initiation  RH → R∙ + H∙ 
Propagation  R∙ + O2 → ROO∙ 
  ROO∙ + RH → ROOH + R∙ 
Termination  R∙ + R∙ → RR 
  RO∙ + RO∙ → ROOR 
In the initiation step, an hydrogen radical is abstracted from an unsaturated fatty acid to form an 
alkyl radical.  During propagation, the alkyl radical reacts with oxygen to form peroxyl radicals, which 
propagates the abstraction of another hydrogen from another unsaturated fatty acid.  This results in the 
formation of a hydroperoxide and a new alkyl radical.  This cyclic process continues until termination, 
when radicals react with each other to form stable non-radical species (Dobarganes 2009). 
Antioxidants help prevent the cellular damage that occurs through oxidation, which is the normal 
pathway for cancer, aging, and many diseases (Simone and Palozza 2008).  Tocols donate hydrogen 
atoms to scavenge lipid peroxyl radicals resulting in the formation of tocopheroxyl radicals, which may 
also scavenge another free radical to form stable products (Chen and others 2011). 
ROO· + TOC → ROOH + TOC· 
 




Tocols are capable of quenching singlet oxygen, ROS and reactive nitrogen species, thus 
terminating the oxidative chain reaction before vital molecules, such as proteins, DNA and lipids, are 
damaged (Ho and others 2008; Simone and Palozza 2008; Moreau and Lampi 2012).  However, 
tocopheroxyl radicals become pro-oxidants when present in high concentrations.  In this case, lipid 
peroxides decompose faster to initiate more oxidations. 
ROOH + TOC· → ROO· + TOC 
 
RH + TOC·→ R· + TOC 
 
It is possible that through metabolic processes, these radicals may be regenerated to tocopherols 
in vivo, though they do not do so in vitro (Seppanen and others 2010). 
There is no clear consensus on the order of antioxidant activity of the tocols.  Some studies show 
different effects of tocotrienols and tocopherols, while others have found similar activities between the 
two.  It is thought that all eight tocols would exert similar activity, because of the side chain at the 2-
position of chromanols (Yoshida and Niki 2008).  When measured in organic solutions to mimic biological 
membranes, α-T has generally been found to be a more potent antioxidant compared to the other tocols.  
This is because it is more capable of donating a hydrogen atom due to its chemical structure (Traber and 
Atkinson 2007).  Also, α-T has two ortho-methyl substituents, which decreases tendency toward oxidation 
(Kamal-Eldin and Appelqvist 1996).  However, because α-T is the most reactive, it is also the most 
unstable, which may cause pro-oxidation activity, thereby decreasing its antioxidant activity in food 
systems (Seppanen and others 2010).  Seppanen and others (2010) report that tocotrienols exhibit better 
antioxidant effects than tocopherols, with γ-T3 having the best effect in oil systems.  Qureshi and others 
(2000a) found that tocotrienols were 4-33-fold more potent antioxidants than α-T, with the order of activity 
being δ-T3>γ-T3>α-T3>α-T in an in vitro liposome system.  This agrees with recent findings of an in vitro 
lipid peroxidation inhibition study by Simone and Palozza (2008). 
However, Xu and others (2001) compared the antioxidant activity of α-T, α-T3, γ-T and γ-T3 and 
found significant similar antioxidant activities in the inhibition of cholesterol oxidation.  In solutions and 
membranes, tocotrienols had similar antioxidant activities to tocopherols (Yoshida and others 2003).  The 
same conclusion was drawn in a study that investigated the eight tocols using five different in vitro assays 
(FRAP, α-TEAC, DPPH, ORAC and CL) (Müller and others 2010). 
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It may be that a combination of tocols offers the best antioxidant protection.  The E vitamer 
fraction of rice bran was found to be as effective at scavenging the free radical DPPH as synthetic 
antioxidants BHT and BHA.  This suggests vitamin E may find use as a natural antioxidant replacement in 
food systems (Kim 2005). 
Cholesterol-Lowering Effects 
High blood cholesterol, especially low-density lipoprotein (LDL) cholesterol, has been shown to 
increase the risk of cardiovascular disease (McClements and Decker 2008).  Cholesterol reduction due to 
the consumption of rice bran, rice bran oil or rice bran products (e.g. defatted rice bran, rice bran oil gum, 
rice bran oil wax) has been reported in hamsters (Newman and others 1992; Kahlon and others 1991, 
1992, 1996; Ausman and others 2005; Wilson and others 2007), humans (Lichtenstein and others 1994; 
Gerhardt and Gallo 1998; Qureshi and others 2002; Most and others 2005; Eady and others 2011), 
monkeys (Nicolosi and others 1991), mice (Hundemer and others 1991) and pigs (Marsono and others 
1993).  Conflicting results have been reported in rats (Topping and others 1990; Anderson and others 
1994), humans (Kestin and others 1990; Lichtenstein and others 1994) and monkeys (Nicolosi and others 
1991; Malinow and others 1976).  The results of these studies suggest that the unsaponifiable 
components (tocotrienols, oryzanol and sterols) are responsible for the hypocholesterolemic abilities of 
rice bran and rice bran oil, as opposed to the fatty acid composition.  It is postulated that tocotrienols, 
especially γ-T3, lower cholesterol by inhibiting HMG-CoA reductase, the rate-limiting enzyme in 
cholesterol biosynthesis (Kerckhoffs and others 2002).  Several studies have shown tocotrienol to inhibit 
HMG-CoA reductase activity (Qureshi and others 1991; Khor and others 1995; Song and others 2006; 
Berbée and others 2009), many focusing on the ability of γ-T3 specifically (Pearce and others 1992; 
Parker and others 1993; Qureshi and others 1986, 2000b). 
Anti-Carcinogenic Effects 
Tocotrienols have been shown to have anti-carcinogenic effects in numerous in vivo and in vitro 
studies, primarily due to their antiproliferative and apoptotic effects.  Direct comparisons between 
tocotrienols and tocopherols show that tocotrienols are significantly more potent than tocopherols and 
exhibit a biopotency relationship of δ-T3≥γ-T3>α-T3>δ-T>>γ-T=α-T (McIntyre and others 2000a, 2000b).   
There is a general consensus among researchers that γ-T3 and δ-T3 are the most potent anti-cancer 
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agents of the known existing tocols (Sen and others 2006).  In many cases, γ-T and α-T were ineffective 
in cancer cell growth inhibition (Yu and others 1999; Nesaretnam and others 1995, 1998, 2000; Sylvester 
and others 2001).  Recently it was found that δ-T3 exerts dose-dependent inhibition of vessel formation in 
mice implanted with human colorectal adenocarcinoma cells (Shibata and others 2008) and apoptosis 
induction in human breast cancer cells, regardless of estrogen receptor status (Shun and others 2004).  
γ-T3 also has the potential for use as a therapeutic dietary supplement, as was seen in a murine model 
where γ-T3 suppressed the growth of melanoma cells, human breast adenocarcinoma and leukemic cells 
(Mo and Elson 1998).   
Tocotrienols have been found to have anti-carcinogenic activity for several types of cancer.  
These compounds have been shown to inhibit the growth of human breast cancer cells (McIntyre and 
others 2000a, 2000b; Nesaretnam and others 1995, 1998, 2000) and to delay the onset and severity of 
induced mammary tumors in mice (Gould and others 1991; Iqbal and others 2003; Nesaretnam and 
others 2004; Abdul Hafid and others 2010).  The exact mechanism of apoptosis induction by tocotrienols 
is unknown, though there are several possible mechanisms, including mediation by caspase activation 
(Shah and others 2003; Sakai and others 2004), inhibition of G-protein-mediated activation of adenylyl 
cyclase and cAMP production (Sylvester and others 2002), endometrial reticulum (ER)-stress-mediated 
apoptosis (Park and others 2010) and disruption of mitochondrial function (Takahashi and Loo 2004).  
Tocotrienols also exhibit protective effects against the severity of hepatocarcinogenesis in rats (Ngah and 
others 1991).  Long-term feeding of tocotrienol-rich fraction (TRF) (6 months) reduced the number of 
neoplastic nodules seen in rats (Rahmat and others 1993; Iqbal and others 2004).  Supplemented TRF 
was shown to play a role in the liver’s ability to clear out toxic substances generated as a result of 
carcinogenesis (Iqbal and others 2003, 2004).  Tocotrienols, specifically γ-T3, have antiproliferative and 
apoptotic effects in prostate cancer cells (Conte and others 2004; Srivastava and Gupta 2006; Yap and 
others 2008), colon carcinoma cells (Agarwal and others 2004; Shibata and others 2010), as well as 
suppression effects in melanoma tumors (He and others 1996). 
In some cases, treatment of tocotrienols combined with another compound may provide 
synergistic effects against cancer cell growth.  Co-supplementation with γ-T3 and β-ionone (an end-ring 
analogue of β-carotenoid known to exert cancer chemopreventive effects in several organs) reduced 
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melanoma cell numbers in mice by 68%, which was greater than the sum of the individual effects (59%) 
(He and others 1996).  Conflicting results have been seen for other combination therapies.  γ-T3 has 
been reported to be a better inhibitor of human breast cancer cells in vitro than tamoxifen, a synthetic 
antiestrogen widely used in hormone therapy of breast cancer.  When used in combination, treatment 
with both TRF and tamoxifen inhibited cell proliferation more effectively than either compound alone 
(Guthrie and others 1997).  In contrast, a recent human clinical trial found no statistically significant 
synergistic effect of combined TRF and tamoxifin therapy on survival of women with early breast cancer 
(Nesaretnam and others 2010).  Inconsistent results have also been reported for α-T and selenium.  In an 
early in vivo study, rats supplemented with both α-T and selenium developed fewer tumors than rats 
given α-T or selenium alone (p<0.05) (Hovarth and Ip 1983).  However, in a more recent study, α-T and 
selenium did not act as chemopreventive agents in the rat prostate, whether administered together or 
alone (McCormick and others 2010).  The mixed results of these studies provide evidence that more 
research is needed to determine the efficacy of synergistic treatments of tocols and other compounds in 
protecting against cancer. 
Other Health Benefits 
Research suggests that vitamin E may be able to reduce the risk of cardiovascular disease and 
stroke (Schaffer and others 2005), protect against neurological disorders such as stroke and Alzheimer’s 
(Morris and others 2005; Das and others 2008; Mangialasche and others 2010) and act as a potential 
therapy for diabetes (Qureshi and others 2001a; Nazaimoon and Khalid 2002; Kuhad and others 2009). 
Interference of Alpha-Tocopherol 
Some studies suggest that α-T may interfere with beneficial effects of tocotrienols.  Shibata and 
others (2010) demonstrated that α-T attenuates the ability of δ-T3 to induce apoptosis in cancerous cells 
by inhibiting cellular uptake of δ-T3.  An abundance of literature has revealed the ability of γ-T3 to lower 
HMG-CoA reductase activity in order to reduce harmful effects of radiation (Pearce and others 1992; 
Parker and others 1993; Qureshi and others 1986; 2000b).  Multiple studies found that in contrast to this 
effect of γ-T3, supplementation with α-T increased HMG-CoA reductase activity in chickens (Pearce and 
others 1992; Qureshi and others 1996, 2000a).  In fact, co-administration of α-T and γ-T3 attenuated the 
impact of γ-T3 in suppressing HMG-CoA reductase activity (Qureshi and others 1996).  α-T has also been 
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shown to increase metabolism of α-T3, but not γ-T3, in rats (Ikeda and others 2003).  The preferential 
retention of α-T and excretion of γ-T3 may be due to the catalytic activity of tocopherol-ω-hydroxylase 
(CYP4F2) (Sontag and Parker 2007).   Tocotrienols are commonly available in the form of tocotrienol-rich 
fraction (TRF), which contains approximately 13-25% tocopherol and 75-87% tocotrienol (Qureshi and 
others 2001b; Sylvester and others 2002).  Therefore, coexisting tocopherol in TRF may interfere with the 
radioprotective and anti-carcinogenic activities of tocotrienols, a potential challenge that should be 

























EXTRACTION AND ANALYSIS OF TOCOLS FROM RICE BRAN OIL DEODORIZER DISTILLATE  
Abstract 
The tocols [alpha (α-T), beta (β-T), gamma (γ-T) and delta (δ-T) tocopherols; alpha (α-T3), beta 
(β-T3), gamma (γ-T3), and delta (δ-T3) tocotrienols] make up the vitamin E family of antioxidants.  
Studies show tocols to have many health benefits. γ-T3 has been shown to protect against harmful 
effects of radiation in mice. During rice bran oil refining up to 90% of tocols in rice bran are lost to the 
deodorizer distillate. The objective of this study was to optimize parameters for isolating tocols from rice 
bran oil deodorizer distillate (RBODD).  NP-HPLC analysis of tocol standards was optimized by testing 
ten mobile phases on a silica column.  Extraction of tocols was optimized by testing three concentration 
solvents (acetonitrile, methanol, ethanol) using various solvent:RBODD ratios (5:1, 10:1, 15:1, 20:1) at 
two temperatures (4°C and -20°C).  Hexane/ethyl acetate/acetic acid (97.3:1.8:0.9) provided baseline 
resolution of all eight tocols.  All interactions including solvent*ratio*temperature had a significant effect 
on tocol levels in the extracts (p<0.0001). Acetonitrile (10:1 ratio, 4°C) was the most efficient solvent with 
extracts containing 57.4 mg total tocopherols/g concentrate and 61.4 mg total tocotrienols/g concentrate.  
These conditions provided extracts with 1.55- and 1.34-fold higher total tocopherols and 2.23- and 1.82-
fold higher total tocotrienols than extracts obtained with ethanol and methanol, respectively.  Tocol 
contents in acetonitrile and ethanol extracts were highest when concentrated at 4°C, while tocol content 
in methanol extracts were highest at -20°C.  Under the optimal conditions described above, tocopherol 
composition was determined to be 34.0% α-T, 3.4% β-T, 44.9% γ-T and 17.4% δ-T and tocotrienol 














Rice bran oil (RBO) produced by the extraction of oil from stabilized rice bran is consumed widely 
in China, Thailand and Japan, among other Asian countries.  Because of its potential as a functional food, 
American usage of RBO has increased in recent years (Cheruvanky and Thummala 1991).  The oil 
component of rice bran is a rich source of the vitamin E compounds tocopherols and tocotrienols.  These 
compounds, collectively known as tocols, possess lipid-soluble antioxidant activity, and exist in nature in 
eight different isoforms: d-α-tocopherol (α-T), d-β-tocopherol (β-T), d-γ-tocopherol (γ-T), d-δ-tocopherol 
(δ-T), d-α-tocotrienol (α-T3), d-β-tocotrienol (β-T3), d-γ-tocotrienol (γ-T3) and d-δ-tocotrienol (δ-T3) 
(Schauss 2008).  Most of the tocols are stripped from the crude RBO during the refining process, 
particularly the deodorization step.  Up to 90% of the tocols present in rice bran are lost to the deodorizer 
distillate, making this by-product a valuable source of health-promoting tocols (Nicolosi and others 1994).   
Tocols, especially tocotrienols, have recently become of major research interest due to their 
potential health benefits (Traber and Atkinson 2007).  Tocols are known to be excellent antioxidants 
capable of scavenging free radicals to protect against oxidative stress (Eitenmiller and Lee 2004), which 
has been linked to a number of diseases, including cancer, cardiovascular disease, diabetes and 
neurodegenerative diseases (e.g. Alzheimer’s, Parkinson’s) (Cross 1987).  Tocols have also been shown 
to lower cholesterol, have in vitro anti-carcinogenic and in vivo anti-tumor effects and reduce the risk of 
other harmful disorders such as stroke, cardiovascular disease and diabetes (Sen and others 2006).  γ-
T3 also has the ability to act as a radiation countermeasure (Kumar and others 2008).  Mice that were 
treated with γ-T3 prior to exposure to a lethal dosage of radiation had increased survival rates, improved 
hematopoietic recovery and reduced vascular oxidative (Ghosh and others 2009; Berbée and others 
2009, 2010, 2011b).  δ-T3 may also provide some significant radioprotective potential (Li and others 
2010).  However, co-administration of α-T caused interference with the hypocholesterolemic and anti-
carcinogenic effects of γ-T3 and δ-T3 and may adversely affect the radioprotective properties of γ-T3 
(Qureshi and others 1996, 2000a; Shibata and others 2010).  Methods for the isolation and quantification 




High-pressure liquid chromatography (HPLC) is the most commonly used chromatographic 
technique for tocol analysis.  Although reversed-phase columns are generally known to be more stable 
and more durable than normal-phase columns, most cannot separate the beta and gamma isomers of 
tocopherols and tocotrienols due to their closely related structures (Kramer and others 1997; Abidi 1999).  
Therefore, most researchers rely on normal-phase HPLC with unmodified silica columns and 
fluorescence detection for tocol analysis (Abidi 1999; Kamal-Eldin and others 2000).  Methods for 
extraction of tocols from simple foods such as vegetable oils have been well established.  However, tocol 
extraction from more complex matrices requires further cleanup steps such as saponification and 
deproteinization.  Alkaline hydrolysis assisted extraction improves the extractability of tocols by destroying 
protein, lipid and carbohydrate complexes, hydrolyzing triacylglycerols and phospholipids and 
transforming tocol esters into corresponding alcohols (Fratianni and others 2002; Eitenmiller and Lee 
2004).  Other extraction methods may be used, though these methods are not as efficient as solvent 
extraction.  Examples of these methods include supercritical fluid extraction, solid-phase extraction and 
pressurized liquid extraction (Sanagi and others 2005; Moreau and Lampi 2012). 
Little research has been done to investigate the isolation of tocols from rice bran oil deodorizer 
distillate (RBODD).  The complex composition of RBODD necessitates reliable analytical techniques for 
the extraction, isolation and analysis of individual tocol components, especially health-promoting 
tocotrienols.  Furthermore, an analytical HPLC method is needed to provide reproducible separation of 
tocols for routine analysis. 
 
Materials and Methods 
 Apparatus.  Chromatographic measurements were made on an HPLC system consisting of a 
Waters Alliance 2690 separations module, a Waters 474 fluorescence detector, and Empower Pro 2 
Software (Waters Corp., Milford, MA).  Peaks were detected at an excitation wavelength of 294 nm and 
an emission wavelength of 326 nm. 
Materials.  Rice bran oil deodorizer distillate (RBODD) samples were provided by Riceland Foods 
(Jonesboro, AR).  The samples were combined and thoroughly mixed to ensure consistent tocol 
distribution, and divided into screw-top 50-ml bottles, with 50-60 g per bottle.  Samples were stored at -
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80°C, and individual bottles were thawed when needed for extraction by incubating bottles at room 
temperature for 4-5 hours, or until product was free of ice crystals.  After thawing, each bottle of RBODD 
was mixed thoroughly before removing subsamples.  Standards of α-, β-, γ- and δ-tocotrienols and α-, β-, 
γ- and δ-tocopherols (94-95% purity) were purchased from Yasoo Health, Inc. (Johnson City, TN). 
 Mobile Phase Optimization.  Mixture of tocol standards (α-, β-, γ- and δ-tocotrienols and 
tocopherols) in hexane were used for testing.  Based on previous literature (Abidi 2000; Kamal-Eldin and 
others 2000; Andersson and others 2008), HPLC separations were carried out on a Luna Silica column 
(250 x 4.6 mm i.d., 5 µm particle size) (Phenomenex, Torrance, CA).  The ten mobile phases tested for 
performance are listed in Table 4.1.  Run time was 35 min.  
Table 4.1 
The different mobile phases used for normal-phase HPLC 
No.  Components Ratio of components  Flow rate 
1  Hexane-ethyl acetate-acetic acid 97.3:1.8:0.9  1.23 ml min-1 
2  Hexane-ethyl acetate-acetic acid 98.4:0.8:0.8  1.23 ml min-1 
3  Hexane-1,4-dioxane 96:4  1.23 ml min-1 
4  Hexane-tert-butyl methyl ether 90:10  1.23 ml min-1 
5  Hexane-tert-butyl methyl ether 96:4  1.23 ml min-1 
6  Hexane-isopropanol 98.8:1.2  1.00 ml min-1 
7  Hexane-isopropanol 99:1  1.00 ml min-1 
8  Hexane-isopropanol 99.3:0.7  1.00 ml min-1 
9  Hexane-isopropanol 99.8:0.2  1.00 ml min-1 
10  Isooctane-ethyl acetate 97.6:2.4  1.23 ml min-1 
 
 Calculation of Peak Resolution.  Peak resolution (RS) was calculated as a measure of the 
separation between two peaks and the efficiency of the column.  This value was expressed as the ratio of 
the distance between the two peak maxima to the mean value of the peak width at base (van Iterson 
2005).  A value of RS>1.0 indicates acceptable resolution between peaks, while RS>1.5 indicates 
complete baseline separation.  The peak resolution was calculated as follows, where RT=retention time, 
W=peak width measured at baseline, a=peak with shorter retention time, b=peak with longer retention 




 Concentration of Tocols from RBODD.  Extraction variables tested include solvent, solvent-to-
RBODD ratio and concentration temperature (Table 4.2).  Tocols were concentrated using the method of 
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Ko and others (2008) with some modifications.  Stock samples of 5 g RBODD were mixed with a solvent 
in the ratios described below in a 250-ml flat-bottom flask (24/40 joint size).   
Table 4.2 
Concentration variables tested in this study 
Solvent Solvent:RBODD ratio Temperature (°C) 
Acetonitrile 5:1 4 
Methanol 10:1 -20 
Ethanol 15:1  
 20:1  
 
The flask was fitted with a reflux condenser and the mixture was brought to boiling then refluxed 
on a hot plate for 30 min to destroy volatiles and aggregative residues.  The mixture was cooled to 
ambient temperature and stored for 24 hours at 4 or -20°C in order to precipitate the cold insoluble sterols 
from the soluble tocols.  A sintered glass absorption filter was used to separate the liquid fraction from the 
insoluble residue.  The solvent was evaporated from the liquid fraction using a Speed Vac concentrator 
(ThermoSavant, Holbrook, NY).   
Extraction of Tocols from Concentrates.  Triplicate samples of 0.5 g were taken from stock 
concentrates prepared using each combination of concentration variables.  Each 0.5 g sample was mixed 
with 4 ml of 5% (w/v) pyrogallol in ethanol and 30 ml of ethanol in a 120-ml flat-bottom flask along with a 
stir bar.  The flask was fitted with a reflux condenser and the mixture heated to boiling.  Once boiling, the 
condenser was removed and 1 ml of 50% (w/v) aqueous potassium hydroxide solution was added to the 
mixture.  The tocols were saponified at 70°C for 30 min with constant stirring.  The flask was placed in an 
ice bath to stop the reaction.  The mixture was transferred to a 500-ml separatory funnel, and 30 ml 
diethyl ether and 20 ml distilled water were added.  The diethyl ether extraction was repeated two times 
and the ether fractions were pooled.  The pooled diethyl ether was washed three times with 20 ml distilled 
water, and then filtered through anhydrous sodium sulfate for 30 min to remove any excess water.  The 
diethyl ether was evaporated using the Speed Vac concentrator.  
Sample Preparation for HPLC Analysis.  Extracts were resolubilized with hexane to a volume of 5 
ml and filtered through a 0.45 µm Millipore membrane before injection into the HPLC.  The tocols were 
analyzed in triplicate using the HPLC conditions described previously. 
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Quantification of Tocols.  The tocol peaks for each sample were identified and the concentration 
was calculated by comparing peak area against the standard curve equation.  
tocol concentration (ppm) = peak area −  intercept
slope
 
This value was converted to display mg tocol isomer/g RBODD concentrate.   
mg tocol
g concentrate
 = tocol concentration ×  final volume ×  dilution factor
initial sample weight
 
Statistical Analysis.  Reported values represent the mean of triplicate samples prepared for each 
treatment.  Analysis of variance (ANOVA) was performed (JMP software v. 10.0, Cary, NC) to determine 
significant differences (p<0.05) in total tocol concentration among various extraction treatments. 
 
Results and Discussion 
Analysis by Normal Phase-HPLC.  With NP-HPLC, tocol separation occurs by adsorption based 
on polarity, which is determined by the degree of methylation on their chromanol rings.  The unsaturation 
on the C16 tail makes tocotrienols slightly more polar than their corresponding tocopherols (Abidi 2000, 
2003).  Beta and gamma isomers have the same number of methyl groups, making complete separation 
challenging.  Gamma isomers have 7,8-dimethyls, which increases their asymmetry and polarity 
compared to beta isomers with 5,8-dimethyls (Kamal-Eldin and others 2000).  The observed elution order 
in this study corresponded with structural characteristics of the tocols and was as follows:  α-T (9.6 
min)!α-T3 (11.6 min)!β-T (14.3 min)! γ-T (16.2 min)!β-T3 (17.7 min)!γ-T3 (20.3 min)!δ-T (25.2 
min)!δ-T3 (32.0 min).   
Peak resolution was best using an isocratic mobile phase consisting of hexane (HX)/ethyl acetate 
(EA)/acetic acid (AA) (97.3:1.8:0.9, v/v) (Figure 4.1).  Resolution ranged from 1.4 to 4.1, indicating that 
the eight vitamin E isomers were baseline separated.   The lowest resolution (Rs=1.4) was seen between 
γ-T and β-T3, due to their structural similarities, though the separation between these isomers was better 
than previous studies that used the same mobile phase (Frattiani and others 2002; Panfili and others 
2003).  This may be due to use of different columns and/or flow rate. 
There was a lack of separation of beta and gamma isomers with use of HX/MTBE and HX/IPA 
mobile phases (Figures 4.2 and 4.3), as has been reported previously (Abidi 2000; Kamal-Eldin and 
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others 2000).  Co-elution of these isomers resulted in Rs=0 for those mobile phases, indicating 
incomplete separation of the vitamers.  Use of 1,4-dioxane (4%) in hexane provided satisfactory 
separation of all eight E-vitamers, though resolution of beta and gamma isomers was not as strong as 
when HX-EA-AA (97.3:1.8:0.9 v/v/v) was used.  The chromatograms obtained using HX-EA-AA 
(98.4:0.8:0.8 v/v/v), HX-MTBE (96:4 v/v) HX-IPA (99.8:0.2 v/v), and isooctane-EA (97.6:2.4 v/v) failed to 
resolve the peaks within the 35-minute run time, making these mobile phases less than ideal for tocol 
analysis in this study (Figures 4.2A and 4.4). 
 
 
Figure 4.1.  Separation of a balanced mixture of tocopherols and tocotrienols on a Phenomenex Luna 
silica column using hexane-ethyl acetate-acetic acid (97.3:1.8:0.9 v/v/v) at 1.23 ml min-1.  Peaks: α-T (α-
tocopherol), α-T3 (α-tocotrienol), β-T (β-tocopherol), γ-T (γ-tocopherol), β-T3 (β-tocotrienol), γ-T3 (γ-




Figure 4.2. Separation of a balanced mixture of tocopherols and tocotrienols on a Phenomenex Luna 
silica column using various mobile phases: (A) hexane-ethyl acetate-acetic acid (98.4:0.8:0.8 v/v/v) at 
1.23 ml min-1; (B) hexane-1,4-dioxane (96:4 v/v) at 1.23 ml min-1 and (C) hexane-methyl-tert-butyl ether 








Figure 4.3.  Separation of a balanced mixture of tocopherols and tocotrienols on a Phenomenex Luna 
silica column using mixtures of isopropanol in hexane as mobile phases: (A) hexane-isopropanol 
(98.8:1.2 v/v) at 1.00 ml min-1; (B) hexane-isopropanol (99:1 v/v) at 1.00 ml min-1 and (C) hexane-








Figure 4.4. Separation of a balanced mixture of tocopherols and tocotrienols on a Phenomenex Luna 
silica column using various mobile phases: (A) hexane-methyl-tert-butyl ether (96:4 v/v) at 1.23 ml min-1; 
(B) hexane-isopropanol (99.8:0.2 v/v) at 1.00 ml min-1 and (C) isooctane-ethyl acetate (97.6:2.4 v/v) at 







Retention Time Drift with New Column.  A new Luna Silica column (250 x 4.6 mm i.d., 5 µm 
particle size) (Phenomenex, Torrance, CA) was purchased for analyzing tocols in RBODD samples.  This 
coincided with a retention time drift for all tocol isomers, resulting in a new run time of 50 min.  A 
chromatogram of tocols in an RBODD sample is seen in Figure 4.5.  In all samples, only seven tocol 
isomers were detected:  α-T, β-T, γ-T, δ-T, α-T3, γ-T3 and δ-T3.  This result was the same as reported by 
Ko and others (2003, 2008).  The elution order remained the same, though the new retention times were 
as follows:  α-T (13.8 min)!α-T3 (16.4 min)!β-T (21.2 min)!γ-T (23.5)!γ-T3 (29.0 min)!δ-T (36.6 
min)!δ-T3 (45.9 min). 
 
 
Figure 4.5.  Chromatogram of tocols in rice bran oil deodorizer distillate. 
 
Concentration of Tocols from RBODD.  Total tocol concentration was significantly affected by 
solvent*ratio*temperature (p<0.0001). 
Solvent Effects.  Three solvents, including acetonitrile, methanol and ethanol were tested for their 
effects on tocol concentration from RBODD. The level of total tocols was highest when acetonitrile was 
used, followed by methanol and ethanol.  Tocol content ranged from 118.8 mg/g using acetonitrile (10:1 
at 4°C) to 76.5 mg/g using methanol (10:1 at -20°C) to 64.5 mg/g using ethanol (10:1 at 4°C).  Acetonitrile 
in 10:1 ratio at 4°C proved to be the most efficient combination of variables for all isomers, especially γ-T3 
(44.6 mg/g).  This concentration is significantly higher than those obtained using methanol (10:1 at -20°C) 
and ethanol (10:1 at 4°C) at their best ratio/temperature combinations (25.5 mg/g and 20.0 mg/g, 
respectively) (Table 4.3).  Ethanol fractionation is commonly used in industrial purification of tocopherols 
from soybean oil deodorizer distillate because sterols are insoluble in cold ethanol while tocopherols are 
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soluble, though some tocopherols co-precipitate with sterols (Shimada and others 2000).  However, this 
study found acetonitrile to be the ideal solvent for tocol concentration from RBODD, which confirms 
findings of Ko and others (2008).  It should be noted that that differences in tocol levels between this 
study and previous studies may be due to differences in deodorizer distillate sources. 
Temperature Effects.  As mentioned above, at 4°C acetonitrile concentrated the highest levels of 
tocols from RBODD.  This was true for all individual isomers as well as total tocols.  At -20°C, α-T, δ-T 
and δ-T3 were concentrated at similar levels using acetonitrile (5:1) and methanol (10:1) (Table 4.3).  At   
-20°C, methanol was the highest performing solvent at all ratios except 20:1.  This indicates that 
temperature has a significant effect on tocol solubility in various solvents.  
Ko and others (2008) did a similar study, testing temperatures ranging from 0°C to 40°C, and 
found tocol levels to increase as temperature decreased, with -20°C being the optimal temperature for 
acetonitrile to concentrate tocols from RBODD.  In the present study, acetonitrile concentrated higher 
levels of tocols at 4°C than at -20°C.  Vitamin E melting point is 2.5-3.5°C, which likely contributed to 
higher tocols at 4°C compared to -20°C in the present study, though this does not explain why tocol 
concentration was highest at -40°C in the study by Ko and others (2008).  These researchers also found 
that relative percentage of tocotrienols increased significantly with decreasing temperature, 
corresponding with significantly decreasing percentage of tocopherols.  In the current study, there was no 
significant upward trend in relative percentages of tocotrienol with temperature decrease.  The differing 
temperature effects seen in these two studies may be due to differences in RBODD source and/or 












Tocol concentrations in RBODD obtained using optimal ratio for each solvent at 4 and -20°C† 
Temp (°C) Solvent Ratio 
Tocopherols  Tocotrienols 
Total Tocols§ α-T β-T γ-T δ-T  α-T3 γ-T3 δ-T3 
4 Acetonitrile 10:1 19.5a 1.9a 25.8a 10.2a  15.6a 44.6a 1.1a 118.8a 
   (16.4)
b (1.6)b (21.7)b (8.6)b  (13.2)a (37.6)a (0.9)b  
4 Methanol 15:1 14.3b 1.3bc 18.6b 6.8bc  7.8b 23.9bc 0.8ab 73.3b 
   (19.4)
a (1.8)b (25.3)a (9.2)b  (10.6)b (32.6)c (1.0)b  
4 Ethanol 10:1 12.8bc 1.1c 16.8bc 6.3c  6.9b 20.0cd 0.6b 64.5bc 
   (19.8)
a (1.7)b (26.1)a (9.8)b  (10.7)b (30.9)cd (0.9)b  
-20 Acetonitrile 5:1 6.4d 1.7ab 8.2d 9.4a  6.8b 19.2cd 1.1a 52.8c 
   (12.2)
c (3.2)a (15.5)c (17.7)a  (12.9)a (36.4)ab (2.1)a  
-20 Methanol 10:1 12.0bc 1.7ab 19.9b 9.2ab  7.0b 25.8b 0.9ab 76.5b 
   (15.7)
b (2.3)b (26.0)a (12.1)b  (9.2)c (33.7)bc (1.1)b  
-20 Ethanol 15:1 11.1c 1.2c 14.1c 5.8c  5.7b 16.0d 0.7b 54.5c 
   (20.3)
a (2.2)b (25.8)a (10.6)b  (10.5)b (29.4)d (1.3)b  †Means of three replicates (mg/g concentrate). Values in parenthesis refer to the percent distribution of each tocol. 
Means within columns followed by the same letter are not significantly different (p<0.05).   
§Tocols: tocopherols + tocotrienols. 
T, tocopherol; T3, tocotrienol. 
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Solvent-to-RBODD Ratio Effects. The optimal solvent-to-RBODD ratio was 10:1 across all 
solvents (Figure 4.6).  For the best solvents at each temperature (acetonitrile at 4°C and methanol at -
20°C) the higher ratios (15:1, 20:1) were less efficient in tocol concentration.  This may be due to excess 
solvent facilitating tocol crystallization, specifically at -20°C (Roland Verhé, personal communication, 13th 
April 2012).   
 
Figure 4.6.  Tocol concentration in RBODD using all combinations of concentration variables.   









Tocol Distribution in RBODD.  The tocol composition of RBODD obtained using acetonitrile (10:1 







The tocotrienol and tocopherol compositions found in the present study differ slightly from those 
reported in previous studies (Orthoefer 2005; Ko and others 2008).  This variation may be attributed to 
differences in rice cultivar and source, environmental effects and deodorizer distillate origin (Bergman and 
Xu 2003; Ko and others 2008).  
The distribution of the tocol isomers in RBODD is shown in Figure 4.7.  γ-T and γ-T3 were the 
predominant tocols, followed by the alpha isomers.  α-T has shown an antagonistic effect on health 
benefits of γ-T3 and δ-T3 (Qureshi and others 1996, 2000a; Shibata and others 2010).  In order to 
produce a tocol-rich fraction from RBODD that is high in γ-T3, purification measures need to be 
developed to minimize the proportion of alpha isomers present in the fraction.  It is possible that this may 
be achieved using flash chromatography.  
 
Figure 4.7.  Distribution of tocols in RBODD. 
Table 4.4 
Tocol Composition of Rice Bran Oil Deodorizer Distillate 
 Tocol (percent) 
 Tocopherol Tocotrienol 
Alpha 34 25 
Beta 3 - 
Gamma 45 73 




 NP-HPLC using hexane-ethyl acetate-acetic acid (97.3:1.8:0.9 v/v/v) (1.23 ml min-1) was shown 
to be an effective method for separating and quantifying tocols from rice bran oil deodorizer distillate. This 
by-product of the rice industry is a rich source of tocopherols and tocotrienols, especially γ-T3.  
Acetonitrile in a 10:1 solvent-to-distillate ratio with an incubation temperature of 4°C may be used to 
efficiently concentrate tocols from RBODD.  Alpha and gamma isomers were the predominant tocols 
present in RBODD.  It is possible that flash chromatography may be able to purify a tocotrienol-rich 
fraction from RBODD while minimizing presence of alpha isomers, which have been shown to have 










































ISOLATION OF GAMMA-TOCOTRIENOL FROM RICE BRAN OIL DEODORIZER DISTILLATE USING 
FLASH CHROMATOGRAPHY 
Abstract 
The tocols [alpha (α-T), beta (β-T), gamma (γ-T) and delta (δ-T) tocopherols; alpha (α-T3), beta 
(β-T3), gamma (γ-T3), and delta (δ-T3) tocotrienols] make up the vitamin E family of antioxidants.  These 
compounds are known to have many health benefits, especially γ-T3, which has been shown to protect 
against harmful effects of radiation exposure.  However, it has been proposed that co-administration with 
α-T may interfere with the radioprotective properties of γ-T3.  The objective of this study was to test 
various flash chromatography conditions for the purification of a fraction with a high proportion of γ-T3 
and a minimal amount of alpha isomers from tocol extract obtained from rice bran oil deodorizer distillate.  
Load size (0.125 g, 0.250 g, 0.500 g, 1.000 g), sample cartridge type (prepacked silica cartridge, empty 
cartridge+Celite 545) and mobile phase gradient (varying proportions of hexane-acetic acid (99.1:0.9 v/v) 
and ethyl acetate-acetic acid (99.1:0.9 v/v)) were evaluated.  Among the loading sizes tested, the 
smallest sample size (0.125 g) provided the best peak resolution.  Loading the sample onto a silica 
cartridge allowed for enhanced peak separation, due to a double pass of sample through silica gel.  A 
linear addition of 0.8% ethyl acetate/acetic acid (99.1:0.9 v/v) to hexane/acetic acid (99.1:0.9 v/v) 
provided a fraction with 69.3 mg/g extract γ-T3, which was 2-fold lower than the most pure γ-T3 fraction 
obtained using hexane/ethyl acetate/acetic acid (97.3/1.8/0.9) as an isocratic mobile phase.  However, γ-
T3 purity was 96.5% (with no alpha isomers present) with addition of 0.8% EA/AA compared to 47.0% 
with the isocratic mobile phase.  Therefore, the ideal flash chromatography method should be determined 









Rice bran oil (RBO) is produced by extracting oil from the heat stabilized rice bran, either by 
hydraulic pressing or solvent extraction.  Crude RBO goes through a series of refining steps, including 
degumming, neutralization, bleaching, dewaxing, winterization and deodorization.  Deodorization employs 
high heat steam distillation to remove volatile compounds that could give RBO undesirable flavor or odor.  
Unsaponifiables, such as vitamin E and sterols, are also removed from the oil resulting in deodorizer 
distillate with a high level of these compounds.  Up to 90% of the tocotrienols present in rice bran may be 
lost to the deodorizer distillate during the refining process (Nicolosi and others 1994). 
 Vitamin E is a family made up of of eight major lipid-soluble antioxidants:  d-α-tocopherol (α-T), d-
β-tocopherol (β-T), d-γ-tocopherol (γ-T), d-δ-tocopherol (δ-T), d-α-tocotrienol (α-T3), d-β-tocotrienol (β-
T3), d-γ-tocotrienol (γ-T3) and d-δ-tocotrienol (δ-T3).  Tocopherols and tocotrienols, collectively called 
tocols, have a 6-chromanol ring at the base of their structure with a hydrocarbon chain at the 2-position.  
The structures of these vitamin E groups differ only in the degree of saturation of their hydrophobic tail, 
with tocopherols being fully saturated and tocotrienols containing three double bonds (Schauss 2008).  α-, 
β-, γ- and δ-tocols are characterized by the number and position of methyl substituents on the aromatic 
ring (DellaPanna 2005). 
 α-T is the only vitamin E compound to meet dietary vitamin E requirements due to its preferential 
retention in the body by hepatic α-T transfer protein (α-TTP) (DellaPanna 2005).  However, all tocols have 
antioxidant activity and may protect against oxidative stress, which has been linked to many diseases, 
such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases (e.g. Alzheimer’s, 
Parkinson’s), among others (Cross 1987; Schauss 2008).  Rice bran (RB) and RBO consumption has 
been shown to reduce cholesterol in numerous studies (Kahlon and others 1991; Qureshi and others 
2002; Ausman and others 2005; Most and others 2005; Eady and others 2011).  These studies suggest 
that the hypocholesterolemic ability of RB products is due to the unsaponifiable content, specifically 
tocotrienols, including γ-T3, and their ability to inhibit HMG-CoA reductase, the rate-limiting enzyme in 
cholesterol biosynthesis (Kerckhoffs and others 2002).  Tocotrienols have also been shown to have much 
more potent antiproliferative and apoptotic effects on carcinogenic cells than tocopherols (McIntyre and 
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others 2000a).  γ-T3 and δ-T3 are generally considered to be the strongest anti-carcinogenic agents of 
the tocol family (Sen and others 2006).  
 It is of special importance due to the recent earthquake-induced nuclear situation at Fukushima 
and the rising threat of radiological terrorism that tocols, especially γ-T3, have the ability to act as 
radiation countermeasures (Kumar and others 2008).  Several studies have been conducted that 
investigate the degree to which γ-T3 ameliorates radiation injury.  Treatment with γ-T3 in irradiated mice 
resulted in increased survival rates, improved hematopoietic recovery and reduced vascular oxidative 
stress caused by irradiation (Ghosh and others 2009; Berbée and others 2009, 2010, 2011b).  It has been 
suggested that δ-T3 may also provide some significant radioprotective potential (Li and others 2010).  
Outside of emergency nuclear situations, the radioprotective effects of γ-T3 and δ-T3 may be useful in 
therapy for radiation treatments in cancer patients as well (Kumar and others 2008).  However, co-
administration of α-T caused interference with the hypocholesterolemic and anti-carcinogenic effects of γ-
T3 and δ-T3, and may adversely affect the radioprotective properties of γ-T3 (Qureshi and others 1996, 
2000a; Shibata and others 2010). 
 There exists a need to isolate tocotrienol rich fraction (TRF) from RBODD that contains a high 
proportion of γ-T3, while minimizing the presence of alpha isomers.  Flash chromatography is commonly 
used for fractionation of mixtures, employing short columns packed with intermediate size particles (40-60 
µm) with accelerated solvent flow achieved by modest pressure.  While resolution is poorer than obtained 
by HPLC, operating costs and time are lower (Poole 2003).  Flash chromatography has been used by 
Qureshi and others (2000a, 2000b, 2001b, 2002) to isolate a TRF from rice bran, with diethyl ether as 
elution solvent.  It would be desirable to develop a method that avoids use of ether, which poses serious 
safety hazards.  An application note by Teledyne Isco, Inc. (AN27, n.d.) used a diol column and a linear 
gradient of increasing isopropanol in hexane to purify tocopherols from corn and soybean oils.  It is 
possible that flash chromatography conditions may be optimized to obtain a fraction rich in γ-T3 for use in 




Materials and Methods 
Apparatus.  Separations were made using a CombiFlash Rf system with a 340CF evaporative 
light scattering detector (ELSD) (Teledyne Isco, Inc., Lincoln, NE).  Fractions were analyzed by normal-
phase HPLC consisting of a Waters Alliance 2690 separations module, a Waters 474 fluorescence 
detector, and Empower 2 Pro Software (Waters Corp., Milford, MA).  Peaks were detected at an 
excitation wavelength of 294 nm and an emission wavelength of 326 nm.  HPLC separations were carried 
out on a Luna Silica column (250 x 4.6 mm i.d., 5 µm particle size) (Phenomenex, Torrance, CA).  Mobile 
phase was hexane-ethyl acetate-acetic acid (97.3/1.8/0.9 v/v/v, 1.23 ml min-1), which was optimized in a 
previous study (See Chapter 4). 
Materials.  Rice bran oil deodorizer distillate (RBODD) samples were provided by Riceland Foods 
(Jonesboro, AR).  The samples were combined and thoroughly mixed to ensure consistent tocol 
distribution, and divided into screw-top 50-ml bottles, with 50-60 g per bottle.  Samples were stored at -
80°C, and individual bottles were thawed when needed for extraction by incubating at room temperature 
for 4-5 hours, or until product was free of ice crystals.  Each bottle of RBODD was mixed thoroughly 
before removing individual sample.  Standards of α-, β-, γ- and δ-tocotrienols and α-, β-, γ- and δ-
tocopherols (94-95% purity) were purchased from Yasoo Health, Inc. (Johnson City, TN). 
Sample Preparation.  Tocol extracts were prepared according to the method described in Chapter 
4.  In short, 5 g RBODD were mixed with 50 ml acetonitrile in a 250-ml flat-bottom flask (24/40 joint size).  
The flask was fitted with a reflux condenser and the mixture was brought to boiling then refluxed on a hot 
plate for 30 min to destroy volatiles and aggregative residues.  The mixture was cooled to ambient 
temperature and stored for 24 hr at 4°C in order to precipitate the cold insoluble sterols from the soluble 
tocols.  A sintered glass absorption filter was used to separate the liquid fraction from the insoluble 
residue.  The solvent was evaporated from the liquid fraction using a Speed Vac concentrator 
(ThermoSavant, Holbrook, NY) to produce tocol concentrate.  The resulting tocol concentrate (~1.75 g) 
was mixed with 14 ml of 5% (w/v) pyrogallol in ethanol and 105 ml ethanol in a 250-ml flat-bottom flask 
along with a stir bar.  The flask was fitted with a reflux condenser and the mixture was heated to boiling.  
Once boiling, the condenser was removed and 3.5 ml of 50% (w/v) aqueous potassium hydroxide solution 
was added to the mixture.  The tocols were saponified at 70°C for 30 min with constant stirring.  The flask 
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was placed in an ice bath to stop the reaction.  The mixture was transferred to a 500-ml separatory 
funnel, and 105 ml diethyl ether and 70 ml distilled water were added.  The diethyl ether extraction was 
repeated two times and the ether fractions were pooled.  The pooled diethyl ether was washed three 
times with 70 ml distilled water and then filtered through anhydrous sodium sulfate for 30 min to remove 
any excess water.  The diethyl ether was evaporated using the Speed Vac concentrator to produce tocol 
extract. 
 Load Capacity.  The loading study was conducted using prepared tocol extract and 12 g RediSep 
Rf Gold normal phase silica columns (20-40 µm particle size) (Teledyne Isco, Inc., Lincoln, NE).  This 
column size has a sample load capacity ranging from 60 mg to 1.2 g.  The following load sizes were 
tested for peak resolution:  0.125 g, 0.250 g, 0.500 g and 1.000 g.  Samples were dissolved in hexane, 
mixed with 5 g Celite 545 (Sigma-Aldrich, St. Louis, MO), dried using a rotary evaporator and packed into 
5-g sample load cartridges.  Single samples were used in order to preserve extract stock extract.  For this 
study, the mobile phase consisted of hexane/ethyl acetate/acetic acid (97.3:1.8:0.9 v/v) for 17 min, 
followed by neat ethyl acetate for 3 min. 
 Sample Cartridge Type.  The optimal sample load size was tested on two types of RediSep Rf 
solid load cartridges (Teledyne Isco, Inc., Lincoln, NE):  5-g empty disposable cartridge and 5-g 
prepacked disposable silica cartridge.  The empty cartridge was prepared by filling the cartridge with a 
slurry mixture of the dissolved sample and Celite 545 (supporting media).  For the prepacked silica 
cartridge preparation, sample was pipetted onto the top of the cartridge.  The ideal cartridge was chosen 
based on peak resolution.  For this study, the mobile phase consisted of hexane-ethyl acetate-acetic acid 
(97.3:1.8:0.9 v/v/v) for 17 min, followed by neat ethyl acetate for 3 min. 
 Gradient Optimization.  The flash chromatography system allows for easy control of mobile phase 
gradient.  The mobile phase consisted of a binary gradient of hexane-acetic acid (99.1:0.9 v/v) (A) and 
ethyl acetate-acetic acid (99.1:0.9 v/v) (B).   The flow rate was 30 ml/min with various linear gradients as 
follows: 
Table 5.1 
Binary gradients tested on flash chromatography 
Time Gradient System ID Number 1 2 3 4 
0-50 min 0-0.8% B 0-1.3% B 0-1.8% B 0-2.3% B 
50-55 min 100% B 100% B 100% B 100% B 
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 The gradient systems in Table 5.1 were compared against the optimal mobile phase for tocol 
analysis determined previously (Chapter 4), which was an isocratic system consisting of hexane-ethyl 
acetate-acetic acid (97.3:1.8:0.9 v/v/v).  The isocratic mobile phase was run for 50 min, followed by neat 
ethyl acetate at 50-55 min to ensure removal of all compounds from the system (system 5). 
Comparison of Two Flash Chromatography Gradient Systems for Isolation of Gamma-
Tocotrienol.  The gradient system in Table 5.1 that provided fractions with the highest levels of γ-T3 with 
minimal presence of other isomers was chosen for tocol quantification.  Duplicate samples of 0.125 g 
extract were pipetted onto prepacked silica cartridges and fractionated by flash chromatography using 
systems 1 and 5 (described above).  Fractions were collected, dried down using the Speed Vac 
concentrator and brought to 5 ml with hexane.  Samples were filtered through a 0.45 µm Millipore 
membrane before injection into the HPLC.  The tocols were analyzed in duplicate using the HPLC 
conditions described previously.   
Quantification of Tocols.  The tocol peaks for each sample were identified and the concentration 
was calculated by comparing peak area against the standard curve equation.  
tocol  concentration  (ppm) = peak  area −  intercept
slope
 
This value was converted to display mg tocol isomer/g RBODD extract.   
mg  tocol
g  extract
 = tocol  concentration  ×   final  volume  ×   dilution  factor
initial  sample  weight
 
 Statistical Analysis.  Reported values represent the mean of duplicate samples prepared using 
each gradient system.  Isomer concentrations and relative percentages for each fraction were analyzed 
by means comparison with student’s t-test (p<0.05) (JMP software v. 10.0, Cary, NC). 
 
Results and Discussion 
 Load Capacity.  Extract samples were loaded onto Celite and packed into empty sample 
cartridges.  Exact load sizes tested for peak resolution were:  0.125 g (Figure 5.1), 0.260 g (Figure 5.2), 
0.502 g (Figure 5.3) and 1.007 g (Figure 5.4).  For all samples, ELSD detected 6-7 peaks.  At the higher 
load sizes, peak separation was poor and peaks were very broad with some exceeding the threshold of 
the detector.  As load size decreased, resolution improved with the smallest load size providing best peak 
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resolution.  This was expected, as separation efficiency generally decreases as loading amount increases 
due to the larger sample size exceeding the column capacity (Wan and others 2008).   Although all load 
sizes tested fall within the capacity of the column (60 mg to 1.2 g), some overload occurred in the larger 
sample sizes (0.502 g and 1.007 g).  This was evident by an overlap of neighboring peaks and a 
decrease in peak resolution.  This is in agreement with previous column chromatography work (Wan and 
others 2008). 
 
Figure 5.1.  Chromatogram obtained using flash chromatography with 0.125 g extract mixed with Celite 
545 and packed into an empty 5-g cartridge.  Gradient mobile phase was 100% hexane-ethyl acetate-








Figure 5.2.  Chromatogram obtained using flash chromatography with 0.260 g extract mixed with Celite 
545 and packed into an empty 5-g cartridge.  Gradient mobile phase was 100% hexane-ethyl acetate-




Figure 5.3.  Chromatogram obtained using flash chromatography with 0.502 g extract mixed with Celite 
545 and packed into an empty 5-g cartridge.  Gradient mobile phase was 100% hexane-ethyl acetate-







Figure 5.4.  Chromatogram obtained using flash chromatography with 1.007 g extract mixed with Celite 
545 and packed into an empty 5-g cartridge.  Gradient mobile phase was 100% hexane-ethyl acetate-



















Sample Cartridge Type.  The sample size that provided best resolution in the loading capacity 
study (~0.125 g) was used to determine which cartridge type gave best peak separation.  When sample 
was mixed with Celite 545 and packed into an empty cartridge, 6 peaks were resolved (Figure 5.1).  
These peaks had slight shoulders, indicating tocol isomers were not fully separated.  When sample was 
placed onto a pre-packed silica cartridge, 9-10 peaks were detected, which were more clearly separated 
due to the double pass of sample through silica (Figure 5.5).  Use of the silica cartridge allows more time 




Figure 5.5.  Chromatogram obtained using flash chromatography with 0.129 g extract loaded into a pre-
packed 5-g silica cartridge.  Gradient mobile phase was 100% hexane-ethyl acetate-acetic acid 











Gradient Optimization.  The flash chromatograms for the isocratic mobile phase and the four 
gradient systems (Table 5.1) are shown in Figures 5.6-5.10. Table 5.2 shows the tocol compositions of 
the labeled fractions in Figures 5.6 and 5.7.  Compounds eluted very quickly (within 15 min) using 100% 
HX-EA-AA (97.3/1.8/0.9 v/v/v), resulting in co-elution (Figure 5.6).  The gradient system which involved 
adding 0.8% EA-AA (99.1:0.9 v/v) to HX-AA (99.1:0.9 v/v) (Figure 5.7) provided the best peak resolution 
of all gradients tested.  As the proportion of EA-AA (99.1:0.9 v/v) was increased, peak resolution 
decreased though co-elution was still evident by slight shoulders (Figures 5.8-5.9).  Peaks were analyzed 
by HPLC to determine which fractions contained the highest proportion of γ-T3 compared to α-T and α-
T3.  Addition of 0.8% EA-AA yielded more fractions with high levels of γ-T3 and low presence of other 
isomers, especially alpha isomers (Figure 5.7).  Addition of 2.3% of the ethyl acetate mixture was unable 
to separate the isomers (Figure 5.10).  This resulted in fractions with both alpha and gamma isomers 
present in large amounts, and no fractions that contained only γ-T3. 
 
 
Figure 5.6.  Chromatogram obtained using flash chromatography with 0.127 g extract loaded onto a 5-g 
prepacked silica cartridge.  Gradient mobile phase was 100% hexane-ethyl acetate-acetic acid 






Figure 5.7.  Chromatogram obtained using flash chromatography with 0.132 g extract loaded onto a 5-g 
prepacked silica cartridge.  Gradient mobile phase was slow addition of 0.8% ethyl acetate-acetic acid 
(99.1:0.9 v/v) to hexane-acetic acid (99.1:0.9 v/v) (50 min)!100% ethyl acetate-acetic acid (99.1:0.9 v/v) 




Figure 5.8.  Chromatogram obtained using flash chromatography with 0.127 g extract loaded onto a 5-g 
prepacked silica cartridge.  Gradient mobile phase was slow addition of 1.3% ethyl acetate-acetic acid 







Figure 5.9.  Chromatogram obtained using flash chromatography with 0.130 g extract loaded onto a 5-g 
prepacked silica cartridge.  Gradient mobile phase was slow addition of 1.8% ethyl acetate-acetic acid 





Figure 5.10.  Chromatogram obtained using flash chromatography with 0.130 g extract loaded onto a 5-g 
prepacked silica cartridge.  Gradient mobile phase was slow addition of 2.3% ethyl acetate-acetic acid 








 Comparison of Two Flash Chromatography Gradient Systems for Isolation of Gamma-
Tocotrienol.  Tocols were quantified for both the fractions obtained by the 0.8% EA-AA gradient (Figure 
5.7) as well as the isocratic mobile phase (Figure 5.6).  The concentration of tocols and their relative 
percentages is shown for each fraction obtained using these methods in Table 5.1 and Figures 5.11 and 
5.12.  Elution order followed the expected pattern, with early fractions containing alpha isomers, followed 
by beta, gamma and delta isomers.  δ-T3 was not present in detectable amounts in any of the fractions.   
System 1 (0.8% EA-AA gradient) fractions A and B contained very small levels of alpha tocols, 
while fractions G and H did not contain tocols in any detectable amount.  The majority of tocols eluted in 
fractions D, E and F for system 1.  Fraction D was composed mostly of equal amounts of α-T and α-T3, 
with negligible amounts of β-T and γ-T.  Composition shifted from alpha isomers to gamma isomers in 
fraction E, with 79.2 mg γ-T/g extract and minor amounts of β-T, β-T3 and α-T3.  γ-T3 content was low in 
fraction E (3.7 mg/g) though it comprised 96.5% of fraction F with 69.3 mg/g.   
System 5 (isocratic conditions) fractions A, B, F and G contained no tocols, with the majority of 
tocols eluting in fractions C, D and E.  As with the equivalent fraction in system 1, system 5 fraction C 
contained mostly α-T and T3, with concentrations of 48.9 mg/g and 4.5 mg/g, respectively.  Fraction D 
contained mostly α-T3 (27.1 mg/g) with minor amounts of α-T, β-T and γ-T.  Fraction E consisted of 47% 
γ-T3 with 138.2 mg/g.  However, this fraction still contained a large amount of γ-T (106.7 mg/g) as well as 
low levels of β-T, δ-T and α-T3.   
Both of the methods in the present study were able to isolate fractions that contain a high 
proportion of γ-T3 with minimal presence of alpha isomers, with much higher γ-T3 purity than a previous 
study by Qureshi and others (2000a).  These researchers used hexane-ether elution by flash 
chromatography to prepare a tocol-rich fraction from rice bran extracts, which contained only 33.5% γ-T3, 










Concentration and relative percentage of tocol isomers for fractions obtained by flash chromatography using different 
gradient conditions† 
Gradient Fraction 





Tocols§ α-T β-T γ-T δ -T α -T3 β -T3 γ-T3 δ-T3 
0.8% EA/AA1 A 0.3    0.6    0.3 0.6 0.9 
  (33.3)    (66.7)    (33.3) (66.7)  
0.8% EA/AA C 0.3        0.3  0.3 
  (100)        (100)   
0.8% EA/AA D 55.9 1.6 0.9  55.5    57.1 55.5 112.6 
  (49.6) (1.3) (0.8)  (49.3)    (50.7) (49.3)  
0.8% EA/AA E  5.3 79.2  0.3 1.0 3.7  81.9 5.0 84.4 
   (5.5) (94.7)  (0.3) (1.0) (3.8)  (97.4) (5.2)  
0.8% EA/AA F   1.5 4.2  0.4 69.3  5.7 69.5 72.3 
    (1.7) (4.8)  (0.5) (96.5)  (6.5) (96.8)  
0.8% EA/AA G            
0.8% EA/AA H            
Isocratic2 A            
Isocratic B            
Isocratic C 48.9    4.5    48.9 4.5 53.4 
  (91.8)    (8.2)    (91.8) (8.2)  
Isocratic D 1.6 1.5 2.4  27.1    5.4 27.1 32.4 
  (5.1) (4.9) (7.9)  (82.1)    (17.9) (82.1)  
Isocratic E  3.1 106.7 46.2 2.3  138.2  156.0 139.4 295.3 
   (1.0) (36.0) (15.7) (0.7)  (47.0)  (52.7) (47.3)  
Isocratic F            
Isocratic G            †Means of two replicates (mg/g extract).  Values in parentheses refer to the relative percent distribution of each tocol per total 
concentration of tocols in each respective fraction. 
1Indicates the gradient system consisting of 0.8% ethyl acetate-acetic acid (99.1:0.9 v/v) + hexane-acetic acid (99.1:0.9 v/v)  
(50 min)!100% ethyl acetate-acetic acid (99.1:0.9 v/v) (5 min) (system 1). 
2Indicates the gradient system consisting of 100% hexane-ethyl acetate-acetic acid (97.3:1.8:0.9 v/v/v) (50 min)!100% ethyl 
acetate (5 min) (system 5). 
§Tocols: tocopherols + tocotrienols. 
T, tocopherol; T3, tocotrienol. 
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 Relative percentages of the predominant isomer in each fraction are shown in Figures 5.11 and 
5.12.  Although system 5 provided a single fraction with a higher concentration of γ-T3, system 1 provided 
a significantly more pure fraction of γ-T3 (96.5% in fraction F compared to 47% in fraction E with system 
5) (p=0.0055).  Therefore, end usage of γ-T3 may determine which gradient system is preferred.  Clinical 
trials with γ-T3 may prefer system 1 due to the purity of the γ-T3 fraction.  The opposite trend was seen 
for α-T, with a significantly more pure (91.8%) fraction with system 5 (fraction C) compared to 49.6% pure 
α-T fraction with system 1 (fraction D) (p=0.0002). δ-T purity was also significantly higher with system 5 
(fraction E) compared to system 1 (fraction F) (p=0.0243), though γ-T purity was better with system 1 
(fraction E) compared to system 5 (fraction E) (p=0.0083).  In terms of isomer concentrations for each 




Figure 5.11.  Composition of fractions obtained using system 1 gradient mobile phase of 0.8% ethyl 
acetate-acetic acid (99.1:0.9 v/v) to hexane-acetic acid (99.1:0.9 v/v) (50 min)!100% ethyl acetate-acetic 
acid (99.1:0.9 v/v) (5 min).  Fraction letters correspond with letters in Figure 5.10.  Relative percentages 





Figure 5.12.  Composition of fractions obtained using obtained System 5 gradient mobile phase of 100% 
hexane-ethyl acetate-acetic acid (97.3:1.8:0.9 v/v/v) (50 min)!100% ethyl acetate (5 min).  Fraction 
letters correspond with letters in Figure 5.11.  Relative percentages of the predominant isomers in each 
fraction are shown.  
 
Conclusion 
The results of this study provide an adequate flash chromatography method for isolating γ-T3 with 
little presence of other tocol isomers from RBODD tocol extract. Peak resolution was best with a load size 
of ~1% column capacity and a 5-g silica sample cartridge coupled with a 12-g silica column.  A linear 
gradient of 0.8% ethyl acetate-acetic acid (99.1:0.9 v/v) to hexane-acetic acid (99.1:0.9 v/v) (50 
min)!100% ethyl acetate-acetic acid (99.1:0.9 v/v) (5 min) gave a fraction (F) with 96.5% γ-T3, which 
contained 69.3 mg/g.  The purity of γ-T3 using these conditions was better than the fraction (E) obtained 
using 100% hexane/ethyl acetate-acetic acid (97.3:1.8:0.9 v/v) (50 min)!100% ethyl acetate (5 min), 







 Rice bran oil deodorizer distillate (RBODD) is a rich source of tocopherols and tocotrienols, 
especially γ-T3.  Research shows that all of the tocol isomers provide some health benefit, including 
protecting against oxidative stress, lowering cholesterol, and ameliorating radiation injury.  Therefore, 
there is a need for acceptable extraction and analysis method for isolation of these isomers.  Acetonitrile 
in a 10:1 solvent-to-distillate ratio with an incubation temperature of 4°C may be used to efficiently 
concentrate tocols from RBODD.  Normal-phase HPLC using hexane-ethyl acetate-acetic acid 
(97.3:1.8:0.9 v/v/v) (1.23 ml min-1) was shown to be an effective method for separating and quantifying 
tocols from RBODD.  It is important to note that alpha and gamma isomers were the predominant tocols 
present in RBODD because co-administration of alpha isomers have been shown to have antagonistic 
effects on the health beneficial properties of tocotrienols.  Flash chromatography may be a useful method 
for obtaining a fraction from RBODD that is rich in γ-T3 with a minimal proportion of alpha tocol isomers.  
This study showed that a smaller loading sample size provided best peak resolution in a flash 
chromatography system, especially when the sample was placed onto a silica cartridge.  A linear gradient 
involving the addition of 0.8% ethyl acetate-acetic acid (99.1:0.9 v/v) to hexane-acetic acid (99.1:0.9 v/v) 
over 50 min was shown to provide a 96.5% pure fraction of γ-T3 (69.3 mg/g extract) with 0% α-tocol.  Use 
of isocratic mobile phase hexane-ethyl acetate-acetic acid (97.3:1.8:0.9 v/v/v) provided a less pure γ-T3 
fraction (47.0%), though concentration was higher (138.2 mg/g).  Therefore, the ideal flash 
chromatography method should be chosen according to the end purpose of the γ-T3 fraction. 
The advantage of flash chromatography is that it uses less solvent than a semi-preparative 
HPLC, though separation is not as complete and sample preparation is lengthy.  Therefore, it is possible 
that this system may be the best route to take for routine separation of tocol isomers from RBODD, 
especially γ-T3.  For future studies, other solvent and gradient conditions should be evaluated for the 
ability to provide more complete baseline separation of all eight tocol isomers.  There is also a need to 
develop a flash chromatography method capable of isolating γ-T3 with minimal sample preparation in 
order to reduce time and solvent usage required by the current method.  Finally, scale-up on the flash 





Abdul Hafid, SRA, Radhakrishnan AK, Nesaretnam K. 2010. Tocotrienols are good adjuvants for 
developing cancer vaccines. BMC Cancer 10(5). 
 
Abidi SL. 1999. Reversed-phase retention characteristics of tocotrienol antioxidants. J Chromatography A 
844:67-75. 
 
Abidi SL. 2000. Chromatographic analysis of tocol-derived lipid antioxidants. J Chromatography A 
881:197-216. 
 
Abidi SL. 2003. Tocol-derived minor constituents in selected plant seed oils. J Am Oil Chem Soc 
80(4):327-333. 
 
Agarwal MK, Agarwal ML, Athar M, Gupta S. 2004. Tocotrienol-rich fraction of palm oil activates p53, 
modulates Bax/Bcl2 ratio and induces apoptosis independent of cell cycle association. Cell Cycle 
3:205-211. 
 
Ahmed MK, Daun JK, Przybylski R. 2005. FT-IR based methodology for quantitation of total tocopherols, 
tocotrienols and plastochromanol-8 in vegetable oils. J Food Comp Anal 18:359-364. 
 
Amaral JS, Casal S, Torres D, Seabra RM, Oliveira BPP. 2005. Simultaneous determination of 
tocopherols and tocotrienols in hazelnuts by a normal phase liquid chromatographic method. Anal 
Sci 21:1545-1548. 
 
Anderson JW, Jones AE, Riddell-Mason S. 1994. Ten different dietary fibers have significantly different 
effects on serum and liver lipids of cholesterol-fed rats. J Nutr 124(1):78-83. 
 
Andersson SC, Rumpunen K, Johansson E, Olsson ME. 2008. Tocopherols and tocotrienols in sea 
buckthorn (Hippophae rhamnoides L.) berries during ripening.  J Agric Food Chem 56:6701-6706. 
 
Ausman LM, Rong N, Nicolosi RJ. 2005. Hypocholesterolemic effect of physical refined rice bran oil: 
studies of cholesterol metabolism and early atherosclerosis in hypercholesterolemic hamsters. J 
Nutr Biochem 16(9):521-529.  
 
Belsnio B. 1988. The anatomy and physical properties of the rice grain. Towards Integrated Commodity 
and Pest Management in Grain Storage. FAO, Rome. 
 
Berbée M, Fu Q, Boerma M, Garg S, Pathak R, Zhou D, Kumar KS, Hauer-Jensen M. 2010. Reduction of 
radiation-induced vascular nitrosative stress by the vitamin E analog gamma-tocotrienol: 
evidence of a role for tetrahydrobiopterin. Int J Radiat Oncol Biol Phys 79:884-891. 
 
Berbée M, Fu Q, Boerma M, Kumar KS, Loose DS, Hauer-Jensen M. 2011a. Mechanisms underlying the 
radioprotective properties of gamma-tocotrienol: comparative gene expression profiling in tocol-
treated endothelial cells. Genes Nutr. Epublished ahead of print. 
 
Berbée M, Fu Q, Boerma M, Wang J, Kumar KR, Hauer-Jensen M. 2009. gamma-Tocotrienol ameliorates 
intestinal radiation injury and reduces vascular oxidative stress after total body irradiation by an 
HMG-CoA reductase-dependent mechanism. Rad Res 171:596-605. 
 
Berbée M, Fu Q, Garg S, Kulkarni S, Kumar KS, Hauer-Jensen M. 2011b. Pentoxifylline enhances the 
radioprotective properties of gamma-tocotrienol: differential effects on the hematopoietic, 




Berbée M. 2011. Novel pharmacological strategies to reduce acute radiation injury. (Doctoral 
Dissertation). Universitaire pers Maastricht. 
Bergman CJ, Xu Z. 2003. Genotype and environment effects on tocopherol, tocotrienol, and gamma-
oryzanol contents of southern U.S. rice. Cereal Chem 80(4):446-449. 
Bichay TJ, Roy RM. 1986. Modification of survival and hematopoiesis in mice by tocopherol injection 
following irradiation. Strahlenther Onkol 162:391-399. 
 
Boerma M, Roberto KA, Hauer-Jensen M. 2008. Prevention and treatment of functional and structural 
radiation injury in the rat heart by pentoxifylline and alpha-tocopherol. Int J Radiation Oncology 
Biol Phys 72(1):170-177. 
 
Burton GW, Traber MG, Acuff RV, Walters DN, Kayden H, Hughes L, Ingold KU. 1998. Human plasma 
and tissue α-tocopherol concentrations in response to supplementation with deuterated natural 
and synthetic vitamin E. Am J Clin Nutr 67:669-684. 
 
Bushberg JT. 2009. Radiation injury. Available from: 
http://www.merckmanuals.com/home/injuries_and_poisoning/radiation_injury/radiation_injury.html
. Accessed 2012 January 5. 
 
Chen B, McClements DJ, Decker EA. 2011. Minor components in food oils: a review of their roles on lipid 
oxidation chemistry in bulk oils and emulsions. Crit Rev Food Sci Nutr 51:901-916. 
Cheruvanky R, Thummala RC. 1991. Nutritional and biochemical aspects of the hypolipidemic action of 
rice bran oil: a review. J Am Coll Nutr 10(4):593-601. 
Conte C, Floridi A, Aisa C, Piroddi M, Floridi A, Galli F. 2004. γ-Tocotrienol metabolism and 
antiproliferative effect in prostate cancer cells. Ann NY Acad Sci 1031:391-394. 
 
Cross CE. 1987. Oxygen radicals and human disease. Ann Int Med 107:526-545. 
 
Cunha SC, Amaral JS, Fernandes JO, Oliveira MBPP. 2006. Quantification of tocopherols and 
tocotrienols in Portuguese olive oils using HPLC with three different detection systems. J Agric 
Food Chem 54:3351-3356. 
 
Das S, Lekli I, Das M, Szabó G, Varadi J, Juhasz B, Bak I, Nesaretam K, Tosaki A, Powell SR, Das DK. 
2008.  Cardioprotection with palm oil tocotrienols: comparision of different isomers. Am J Physiol 
Heart Circ Physiol 294:H970-H978. 
 
de Deckere EAM, Korver O. 1996. Minor constituents of rice bran oil as functional foods. Nutr Rev 
54(11):S120-126. 
 
Delanian S, Porcher R, Balla-Mekias S, Lefaix JL. 2003. Randomized, placebo-controlled trial of 
combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis. J 
Clin Oncol 21:2545-2550. 
 
DellaPanna D. 2005. Progress in the dissection and manipulation of vitamin E synthesis. Trends Plant Sci 
10(12):574-579. 
 
Dobarganes MC. 2009. Formation of new compounds during frying: general observations. The AOCS 
Lipid Library. Available from: http://lipidlibrary.aocs.org/frying/c-newcpds/index.htm. Accessed 
2012 February 24. 
 




Eady S, Wallace A, Willis J, Scott R, Frampton C. 2011. Consumption of a plant sterol-based spread 
derived from rice bran oil is effective at reducing plasma lipid levels in mildly 
hypercholesterolemic individuals. Brit J Nutr 105:1808-1818. 
 
Eitenmiller R, Lee J. 2004. Vitamin E: Food Chemistry, Composition, and Analysis. New York: Marcel 
Dekker, Inc. 530 p. 
 
Evans HM, Bishop KS. 1922. On the existence of a hitherto unrecognized dietary factor essential for 
reproduction. Science 56:650-651. 
 
Felemovicius I, Bonsack ME, Baptista ML, Delaney JP. 1995. Intestinal radioprotection by vitamin E 
(alpha-tocopherol). Ann Surgery 222(4):504-510. 
 
Fratianni A, Caboni M, Irano M, Panfili G. 2002. A critical comparison between traditional methods and 
supercritical carbon dioxide extraction for the determination of tocochromanols in cereals. Eur 
Food Res Technol 215:353-358. 
 
Fu Q, Berbée M, Boerma M, Wang J, Smid HA, Hauer-Jensen M. 2009. The somatostatin analog 
SOM230 (Pasireotide) ameliorates injury of the intestinal mucosa and increases survival after 
total body irradiation by inhibition exocrine pancreatic secretion. Radiat Res 171:698-707. 
 
Gerhardt AL, Gallo NB. 1998. Full-fat rice bran and oat bran similarly reduce hypercholesterolemia. J Nutr 
128(5):865-869.  
 
Ghosh SP, Hauer-Jensen M, Kumar SK. 2008. Chemistry of tocotrienols. In: Watson RR, Preedy VR, 
editors. Tocotrienols: Vitamin E Beyond Tocopherols. Boca Raton: CRC Press. p 85-96. 
 
Ghosh SP, Kulkarni S, Hieber K, Toles R, Romanyukha L, Kao T-C, Hauer-Jensen M, Kumar KS. 2009. 
Gamma-tocotrienol, a tocol antioxidant as a potent radioprotector. Int J Radiat Biol 85(7):598-606. 
 
Gould MN, Haag JD, Kennan WS, Tanner MA, Elson CE. 1991. A comparison of tocopherol and 
tocotrienol for the chemoprevention of chemically induced rat mammary tumors. Am J Clin Nutr 
53:1068S-1070S. 
 
Gregory III JF. 2008. Vitamins. In: Damodaran S, Parkin K, Fennema O, editors. Fennema’s Food 
Chemistry, 4th ed. Boca Raton: CRC Press. p 439-521. 
 
Grigoriadou D, Androulaki A, Psomiadou E, Tsimidou MZ. 2007. Solid phase extraction in the analysis of 
squalene and tocopherols in olive oil. Food Chem 105:675-680. 
 
Guthrie N, Gapor A, Chambers AF, Carroll KK. 1997. Inhibition of proliferation of estrogen receptor-
negative MDA-MB-435 and -positive MCF-7 human breast cancer cells by palm oil tocotrienols 
and tamoxifen, alone and in combination. J Nutr 127(3):544S-548S. 
 
He L, Mo H, Hadisusilo S, Qureshi AA, Elson CE. 1996. Isoprenoids suppress the growth of murine B16 
melanomas in vitro and in vivo. J Nutr 127(5):668-674. 
 
Heinemann RJB, Xu Z, Godber JS, Lanfer-Marquez UM. 2008. Tocopherols, tocotrienols, and γ-oryzanol 
contents in Japonica and Indica subspecies of rice (Oryza sativa L.) cultivated in Brazil. Cereal 
Chem 85(2):243-247. 
 
Ho C-T, Rafi MM, Ghai G. 2008. Bioactive substances: nutraceuticals and toxicants. In: Damodaran S, 





Hovarth PM, Ip C. 1983. Synergistic effect of vitamin E and selenium in the chemoprevention of 
mammary carcinogenesis in rats. Cancer Res 43:533S-541S. 
 
Hundemer JK, Nabar SP, Shriver BJ, Forman LP. 1991. Dietary fiber sources lower blood cholesterol in 
C57BL/6 mice. J Nutr 121:1360-1365. 
 
Ikeda S, Tohyama T, Yoshimura H, Hamamura K, Abe K, Yamashita K. 2003. Dietary α-tocopherol 
decreases α-tocotrienol but not γ-tocotrienol concentration in rats. J Nutr 2:428-434. 
 
Institute of Medicine. 2000. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and 
Carotenoids. Washington, D.C.: National Academies Press, 506 p. 
 
Iqbal J, Minhajuddin M, Beg ZH. 2003. Suppression of 7,12-dimethylbenz[α]anthracene-induced 
carcinogenesis and hypercholesterolemia in rats by tocotrienol-rich fraction isolated from rice 
bran oil. Eur J Canc Prev 12(6):447-453. 
 
Iqbal J, Minhajuddin M, Beg ZH. 2004. Suppression of diethylnitrosamine and 2-acetylaminofluorene-
induced hepatocarcinogenesis in rats by tocotrienol-rich fraction isolated from rice bran oil. Eur J 
Canc Prev 13(6):515-520. 
 
Ito VM, Martins PF, Batistella CB, Wolf Maciel MR. 2005. Tocopherols and phytosterols concentration 
from soybean oil deodorizer distillate. 4th Mercosur Congress on Process Systems Engineering, 
Costa Verde, Brazil. 
 
Kahlon TS, Chow FI, Chiu MM, Hudson CA, Sayre RN. 1996. Cholesterol-lowering by rice bran and rice 
bran oil unsaponifiable matter in hamsters. Cereal Chem 73(1):69-74. 
 
Kahlon TS, Chow FI, Sayre RN, Betschart AA. 1991. Cholesterol-lowering in hamsters fed rice bran at 
various levels, defatted rice bran and rice bran oil. J Nutr 122(3):513-519. 
 
Kahlon TS, Saunders RM, Sayre RN, Chow FI, Chiu MM, Betschart AA. 1992. Cholesterol-lowering 
effects of rice bran and rice bran oil fractions in hypercholesterolemic hamsters. Cereal Chem 
69:485-489. 
 
Kamal-Eldin A, Appelqvist L-Å. 1996. The chemistry and antioxidant properties of tocopherols and 
tocotrienols. Lipids 31:671-701. 
 
Kamal-Eldin A, Görgen S, Pettersson J, Lampi A-M. 2000. Normal-phase high-performance liquid 
chromatography of tocopherols and tocotrienols: comparison of different chromatographic 
columns. J Chromatography A 881:217-227. 
 
Kerckhoffs DAJM, Brouns F, Hornstra G, Mensink RP. 2002. Effects on the human serum lipoprotein 
profile of β-glucan, soy protein and isoflavones, plant sterols and stanols, garlic and tocotrienols. 
J Nutr 132:2494-2505. 
 
Kestin M, Moss R, Clifton PM, Nestel PJ. 1990. Comparative effects of three cereal brans on plasma 
lipids, blood pressure, and glucose metabolism in mildly hypercholesterolemic men. Am J Clin 
Nutr 52(4):661-666. 
 
Khor HT, Chieng DY, Ong KK. 1995. Tocotrienols inhibit liver HMG CoA reductase activity in the guinea 
pig. Nutr Res 15(4):537-544. 
 
Kim J. 2005. Radical scavenging capacity and antioxidant activity of the E vitamer fraction in rice bran. J 
Food Sci 70:C208-C213.  
 
 67 
Ko S-N, Kim C-J, Kim H, Kim C-T, Chung S-H, Tae B-S, Kim I-H. 2003. Tocol levels in milling fractions of 
some cereal grains and soybean. JAOCS 80(6):585-589. 
Ko S-N, Lee S-M, Kim I-H. 2008. The concentration of tocols from rice bran oil deodorizer distillate using 
solvent. Eur J Lipid Sci Technol 110:914-919. 
 
Kramer JKG, Blais L, Fouchard RC, Melnyk RA, Kallury KMR. 1997. A rapid method for the determination 
of vitamin E forms in tissues and diet by high-performance liquid chromatography using a normal-
phase diol column. Lipids 32(3):323-330. 
 
Kuhad A, Bishnoi M, Tiwari V, Chopra K. 2009. Suppression of NF-κβ signaling pathway by tocotrienol 
can prevent diabetes associated cognitive deficit. Pharmacol Biochem Behav 92:251-259. 
 
Kulkarni S, Ghosh SP, Satyamitra M, Mog S, Hieber K, Romanyukha L, Gambles K, Toles R, Kao T-C, 
Hauer-Jensen M, Kumar KS. 2010. Gamma-tocotrienol protects hematopoietic stem and 
progenitor cells in mice after total body irradiation. Radiat Res 173:738-747. 
 
Kumar KS, Srinivasan V, Toles R, Jobe L, Seed T. 2002. Nutritional approaches to radioprotection: 
vitamin E. Mil Med 167:57-59. 
 
Kumar SR, Ghosh SP, Hauer-Jensen M. 2008. Gamma-tocotrienol: potential as a countermeasure 
against radiological threat. In: Watson RR, Preedy VR, editors. Tocotrienols: Vitamin E Beyond 
Tocopherols. Boca Raton: CRC Press. p 379-398. 
 
Lampi A-M, Nurmi T, Ollilainen V, Piironen V. 2008. Tocopherols and tocotrienols in wheat genotypes in 
the HEALTHGRAIN Diversity Screen. J Agric Food Chem 56:9716-9721. 
 
Lampi A-M. 2011. Analysis of tocopherols and tocotrienols by HPLC. The AOCS Lipid Library. Available 
from: http://lipidlibrary.aocs.org/topics/tocopherols/index.htm. Accessed 2012 January 24. 
 
Lanina SA, Toledo P, Sampels S, Kamal-Eldin A, Jastrebova JA. 2007. Comparison of reversed-phase 
liquid chromatography-mass spectrometry with electrospray and atmospheric pressure chemical 
ionization for analysis of dietary tocopherols. J Chromatography A 1157:159-170. 
 
Lee B-L, New A-L, Ong C-N. 2003. Simultaneous determination of tocotrienols, tocopherols, retinol, and 
major carotenoids in human plasma. Clin Chem 49(12):2056-2066. 
 
Lee J, Ye L, Landen Jr. WO, Eitenmiller RR. 2000. Optimization of an extraction procedure for the 
quantification of vitamin E in tomato and broccoli using response surface methodology. J Food 
Comp Anal 13:45-57. 
 
Leo L, Rescio L, Ciurlia L, Zacheo G. 2005. Supercritical carbon dioxide extraction of oil and α-tocopherol 
from almond seeds. J Sci Food Agric 85:2167-2174. 
 
Li XH, Fu D, Latif NH, Mullaney CP, Ney PH, Mog SR, Whitnall MH, Srinivasan V, Xiao M. 2010. δ-
Tocotrienol protects mouse and human hematopoietic progenitors from γ-irradiation through 
extracellular signal-regulated kinase/mammalian target of rapamycin signaling. Haematologica 
95(12):1996-2004. 
 
Lichtenstein AH, Ausman LM, Carrasco W, Gualtieri LJ, Jenner JL, Ordovas JM, Nicolosi RJ, Goldin BR, 
Schaefer EJ. 1994. Rice bran oil consumption and plasma lipid levels in moderately 
hypercholesterolemic humans. Arterioscler Thromb Vasc Biol 14:549-556. 
 
Lim H, Woo S, Kim HS, Jong S-K, Lee J. 2007. Comparison of extraction methods for determining 




Malinow MR, McLaughlin IP, Papworth L, Naito HK, Lewis LA. 1976. Effect of bran and cholestyramine 
on plasma lipids in monkeys. Am J Clin Nutr 29(8):905-911. 
 
Mangialasche F, Kivipelto M, Mecocci P, Rizzuto D, Palmer K, Winblad B, Fratiglioni L. 2010. High 
plasma levels of vitamin E forms and reduced Alzheimer’s disease risk in advanced age. J 
Alzheimer’s Disease 20:1029-1037. 
 
Marsono Y, Illman RJ, Clarke JM, Trimble RP, Topping DL. 1993. Plasma lipids and large bowel volatile 
fatty acids in pigs fed on white rice, brown rice and rice bran. Brit J Nutr 70(2):503-513. 
 
McCaskill DR, Orthoefer FT. 1994. Storage stability of extrusion stabilized and parboiled rice bran. In: , 
Marshall WE, Wadsworth JI, editors. Rice Science and Technology. New York: Marcel Dekker, 
Inc. p 37-47. 
 
McClements D, Decker E. 2008. Lipids. In: Damodaran S, Parkin K, Fennema O, editors. Fennema’s 
Food Chemistry, 4th ed. Boca Raton: CRC Press. p 155-216. 
 
McCormick DL, Rao KVN, Johnson WD, Bosland MC, Lubet RA, Steele VE. 2010. Null activity of 
selenium and vitamin E as cancer chemopreventive agents in the rat prostate. Canc Prev Res 
3:381-392. 
 
McIntyre BS, Briski KP, Gapor A, Sylvester PW. 2000a. Antiproliferative and apoptotic effects of 
tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. 
Proc Soc Exp Biol Med 224(4):292-301. 
 
McIntyre BS, Briski KP, Tirmenstein MA, Fariss MW, Gapor A, Sylvester PW. 2000b. Antiproliferative and 
apoptotic effects of tocopherols and tocotrienols on normal mouse mammary epithelial cells. 
Lipids 35:171-180. 
 
Mo H, Elson CE. 1998. Apoptosis and cell-cycle arrest in human and murine tumor cells are initiated by 
isoprenoids. J Nutr 129:804-813. 
 
Moreau RA, Flores RA, Hicks KB. 2007. Composition of functional lipids in hulled and hulless barley in 
fractions obtained by scarification and in barley oil. Cereal Chem 84:1-5. 
 
Moreau RA, Lampi A-M. 2012. Analysis methods for tocopherols and tocotrienols. In: Xu Z, Howard LR, 
editors. Analysis of Antioxidant-Rich Phytochemicals. New York: John Wiley & Sons, Inc. p 353-
386. 
 
Moreau RA. 2006. The analysis of lipids via HPLC with a charged aerosol detector. Lipids 41:727-734. 
 
Morris MC, Evans DA, Tangney CC, Bienias JL, Wilson RS, Aggarwal NT, Scherr PA. 2005. Relation of 
the tocopherol forms to incident Alzheimer disease and to cognitive change. Am J Clin Nutr 
81:508-514. 
 
Most MM, Tulley R, Morales S, Lefevre M. 2005. Rice bran oil, not fiber, lowers cholesterol in humans. 
Am J Clin Nutr 81(1):64-68. 
 
Müller L, Theile K, Bohm V. 2010. In vitro antioxidant activity of tocopherols and tocotrienols and 
comparison of vitamin E concentration and lipophilic antioxidant capacity in human plasma. Mol 
Nutr Food Res 54:731-742. 
 
Mutlu-Türkoğlu Ü, Erbil Y, Öztezcan S, Olgaç V, Toker G, Uysal M. 2000. The effect of selenium and/or 




National Agricultural Statistics Service (NASS). 2011. Crop production report. Available from: 
http://www.nass.usda.gov/Statistics_by_State/Arkansas/Publications/Crop_Releases/Crop_Produ
ction_Monthly/2011/crpdnov11.pdf. Accessed 2012 February 6. 
 
National Comprehensive Cancer Network (NCCN). n.d. Safety in radiation therapy.  Obtained from 
National Comprehensive Cancer Network website. Available from: 
http://www.nccn.com/understanding-cancer/829-safety-in-radiation-therapy.html.  Accessed 2012 
January 4. 
 
Nazaimoon WMW, Khalid BAK. 2002. Tocotrienols-rich diet decreases advanced glycosylation end-
products in non-diabetic rats and improves glycemic control in streptozotocin-induced diabetic 
rats. Malaysian J Pathol 24(2):77-82. 
 
Nesaretnam K, Ambra R, Selvaduray KR, Radhakrishnan A, Reimann K, Razak G, Virgili F. 2004. 
Tocotrienol-rich fraction from palm oil affects gene expression in tumors resulting from MCF-7 cell 
inoculation in athymic mice. Lipids 39(5):459-467. 
 
Nesaretnam K, Dorasamy S, Darbre PD. 2000. Tocotrienols inhibit growth of ZR-75-1 breast cancer cells. 
Int J Food Sci Nutr 51:S95-S103. 
 
Nesaretnam K, Guthrie N, Chambers AF, Carroll KK. 1995. Effect of tocotrienols on the growth of human 
breast cancer cell line in culture. Lipids 30(12):1139-1143. 
 
Nesaretnam K, Selvaduray KR, Razak GA, Veerasenan SD, Gomez PA. 2010. Effectiveness of 
tocotrienol-rich fraction combined with tamoxifen in the management of women with early breast 
cancer: a pilot clinical trial. Breast Canc Res 12:R81. 
 
Nesaretnam K, Stephen R, Dils R, Darbre P. 1998. Tocotrienols inhibit the growth of human breast 
cancer cells irrespective of estrogen receptor status. Lipids 33(5):461-469. 
 
Newman RK, Betschart AA, Newman CW, Hofer PJ. 1992. Effect of full-fat or defatted rice bran on serum 
cholesterol. Plant Foods Hum Nutr 42(1):37-43. 
 
Ngah WZW, Jarien Z, San MM, Marzuki A, Top GM, Shamaan NA, Kadir KA. 1991. Effect of tocotrienols 
on hepatocarcinogenesis by 2-acetylaminofluorene in rats. Am J Clin Nutr 53:1076S-1081S. 
 
Nicolosi RJ, Ausman LM, Hegsted DM. 1991. Rice bran oil lowers serum-cholesterol, LDL and apo B 
levels in nonhuman primates. Atherosclerosis 88:133-142. 
 
Nicolosi RJ, Rogers EJ, Ausman LM, Orthoefer FT. 1994. Rice bran oil and its health benefits. In: 
Marshall WE, Wadsworth JI, editors. Rice Science and Technology. New York: Marcel Dekker. p 
421-437.  
 
Okunieff P, Augustine E, Hicks JE, Cornelison TL, Altemus RM, Naydich BG, Ding I, Huser AK, Abraham 
EH, Smith JJ, Coleman N, Gerber LH. 2004. Pentoxifylline in the treatment of radiation-induced 
fibrosis. J Clin Oncol 22(11):2207-2213. 
Orthoefer FT. 2005. Rice bran oil. In: Shahidi F, editor. Bailey’s Industrial Oil and Fat Products, Sixth 
Edition, Six Volume Set. New York: John Wiley & Sons, Inc.  p 465-489. 
Panfili G, Fratianni A, Irano M. 2003. Normal phase high-performance liquid chromatography method for 
the determination of tocopherols and tocotrienols in cereals. J Agric Food Chem 51:3940-3944. 
 
Park SK, Sanders BG, Kline K. 2010. Tocotrienols induce apoptosis in breast cancer cell lines via an 
endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling. Breast 
Canc Res Treat 124:361-375. 
 
 70 
Parker RA, Pearce BC, Clark RW, Gordon DA, Wright JJK. 1993. Tocotrienols regulate cholesterol 
production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl 
coenzyme A reductase. J Biol Chem 268:11230-11238. 
 
Pearce BC, Parker RA, Deason ME, Qureshi AA, Wright JJK. 1992. Hypocholesterolemic activity of 
synthetic and natural tocotrienols. J Med Chem 35:3595-3606. 
 
Peterson DM, Jensen CM, Hoffman DL, Mannerstedt-Fogelfors B. 2007. Oat tocols: saponification vs. 
direct extraction and analysis in high-oil genotypes. Cereal Chem 84(1):56-60. 
Poole CF. 2003. The Essence of Chromatography. Amsterdam, The Netherlands: Elsevier Science. p 
847-900. 
Puoci F, Cirillo G, Curcio M, Iemma F, Spizzirri UG, Picci N. 2007. Molecularly imprinted solid phase 
extraction for the selective HPLC determination of α-tocopherol in bay leaves. Analytica Chimica 
Acta 593:164-170. 
 
Qureshi AA, Burger WC, Peterson DM, Elson CE. 1986. The structure of an inhibitor of cholesterol 
biosynthesis isolated from barley. J Biol Chem 261(3):10544-10550. 
 
Qureshi AA, Mo H, Packer L, Peterson DM. 2000a. Isolation and identification of novel tocotrienols from 
rice bran with hypocholesterolemic, antioxidant, and antitumor properties. J Agric Food Chem 
48:3130-3140. 
 
Qureshi AA, Pearce BC, Nor RM, Gapor A, Peterson DM, Elson CE. 1996. Dietary α-tocopherol 
attenuates the impact of γ-tocotrienol on hepatic 3-hydroxy-3-methylglutaryl coenzyme A 
reductase activity in chickens. J Nutr 126(2):389-394. 
 
Qureshi AA, Peterson DM. 2001. The combined effects of novel tocotrienols and lovastatin on lipid 
metabolism in chickens. Atherosclerosis 156:39-47. 
 
Qureshi AA, Peterson DM, Hasler-Rapacz JO, Rapacz J. 2000b. Novel tocotrienols of rice bran suppress 
cholesterogenesis in hereditary hypercholesterolemic swine. J Nutr 131(2):223-230. 
 
Qureshi AA, Qureshi N, Wright JJK, Shen Z, Kramer G, Gapor A, Chong YH, DeWitt G, Ong ASH, 
Peterson DM, Bradlow BA. 1991. Lowering of serum cholesterol in hypercholesterolemic humans 
by tocotrienols (palmvitee). Am J Clin Nutr 53:10215-10265. 
 
Qureshi AA, Sami SA, Khan FA. 2001a. Effects of stabilized rice bran, its soluble and fiber fractions on 
blood glucose levels and serum lipid parameters in humans with diabetes mellitus Types I and II. 
J Nutr Biochem 13:175-187. 
 
Qureshi AA, Sami SA, Salser WA, Khan FA. 2001b. Synergistic effect of tocotrienol-rich fraction (TRF25) 
of rice bran and lovastatin on lipid parameters in hypercholesterolemic humans. J Nutr Biochem 
12:318-329. 
 
Qureshi AA, Sami SA, Salser WA, Khan FA. 2002. Dose-dependent suppression of serum cholesterol by 
tocotrienol-rich fraction (TRF25) of rice bran in hypercholesterolemic humans. Atherosclerosis 
161(1):199-207. 
 
Rahmat A, Ngah WZW, Shamaan NA, Gapor A, Kadir KA. 1993. Long-term administration of tocotrienols 
and tumor-marker enzyme activities during hepatocarcinogenesis in rats. Nutr 9(3):229-232. 
 





Rice Knowledge Bank. 2009. Rice milling. Available from: 
http://www.knowledgebank.irri.org/rkb/index.php/rice-milling/byproducts-and-their-utilization. 
Accessed 2012 February 27. 
 
Roy GK, Chandra HNS. 1975. Rice bran oil: an important future source for edible and essential oils in 
Orissa. J Inst Eng (India):69-73. Available from: http://hdl.handle.net/2080/1006. Accessed 2012 
August 6. 
 
Ryynänen M, Lampi A-M, Salo-Väänänen P, Ollilainen V, Piironen,V. 2004. A small-scale sample 
preparation method with HPLC analysis for determination of tocopherols and tocotrienols in 
cereals. J Food Comp Anal 17:749-765. 
 
Sakai M, Okabe M, Yamasaki M, Tachibana H, Yamada K. 2004. Induction of apoptosis by tocotrienol in 
rat hepatoma dRLh-84 cells. Anticanc Res 24:1683-1688. 
 
Sanagi MM, See HH, Ibrahim WAW, Naim AA. 2005. Determination of carotene, tocopherols and 
tocotrienols in residue oil from palm pressed fiber using pressurized liquid extraction-normal 
phase liquid chromatography. Analytica Chimica Acta 538:71-76. 
 
Schaffer S, Müller WE, Eckert GP. 2005. Tocotrienols: constitutional effects in aging and disease. J Nutr 
135:151-154. 
 
Schauss AG. 2008. Tocotrienols: a review. In: Watson RR, Preedy VR, editors. Tocotrienols: Vitamin E 
Beyond Tocopherols. Boca Raton: CRC Press. p 3-12. 
 
Schwartz H, Ollilainen V, Piironen V, Lampi A-M. 2008. Tocopherol, tocotrienol and plant sterol contents 
of vegetable oils and industrial fats. J Food Comp Anal 21(2):152-161. 
 
Sen CK, Khanna S, Roy S. 2006. Tocotrienols: vitamin E beyond tocopherols. Life Sci 78:2088-2098. 
 
Sen CK, Khanna S, Roy S. 2007. Tocotrienols in health and disease: the other half of the natural vitamin 
E family. Mol Aspects Med 28:692-728. 
 
Seppanen CM, Song Q, Csallany AS. 2010. The antioxidant functions of tocopherol and tocotrienol 
homologues in oils, fats, and food systems. J Am Oil Chem Soc 87:469-481. 
 
Shah S, Gapor A, Sylvester PW. 2003. Role of caspase-8 activation in mediating vitamin E-induced 
apoptosis in murine mammary cancer cells. Nutr Canc 45(2):236-246. 
 
Shibata A, Nakagawa K, Sookwong P, Tsuduki T, Asai A, Miyazawa T. 2010. α-Tocopherol attenuates 
the cytotoxic effect of δ-tocotrienol in human colorectal adenocarcinoma cells. Biochem Biophys 
Res Comm 397:214-219. 
 
Shibata A, Nakagawa K, Sookwong P, Tsuzuki T, Oikawa S, Miyazawa T. 2008. Tumor anti-angiogenic 
effect and mechanism of action of δ-tocotrienol. Biochem Pharmacol 76:330-339. 
Shimada Y, Nakai S, Suenaga M, Sugihara A, Kitano M, Tominaga Y. 2000. Facile purification of 
tocopherols from soybean oil deodorizer distillate in high yield using lipase. J Am Oil Chem Soc 
77(10):1009-1013. 
Shin T-S, Godber JS, Martin DE, Wells JH. 1997. Hydrolytic stability and changes in E vitamers and 
oryzanol of extrude rice bran during storage. J Food Sci 62(4):704-709.  
 
Shin T-S, Godber JS. 1994. Isolation of four tocopherols and four tocotrienols from a variety of natural 




Shun M-C, Yu W, Gapor A, Parsons R, Atkinson J, Sanders BG, Kline K. 2004. Pro-apoptotic 
mechanisms of action of a novel vitamin E analog (α-TEA) and a naturally occurring form of 
vitamin E (δ-tocotrienol) in MDA-MB-435 human breast cancer cells. Nutr Canc 48(1):95-105. 
 
Silva SD, Rosa NF, Ferreira AE, Boas LV, Bronze MR. 2008. Rapid determination of α-tocopherol in 
vegetable oils by Fourier Transform Infrared spectroscopy. Food Anal Meth 2:120-127. 
 
Simone R, Palozza P. 2008. Antioxidant activity of tocotrienols in cells and serum. In: Watson RR, Preedy 
VR, editors. Tocotrienols: Vitamin E Beyond Tocopherols. Boca Raton: CRC Press. p 99-108. 
 
Singh VK, Brown DS, Kao T-C. 2010. Alpha-tocopherol succinate protects mice from gamma-radiation by 
induction of granulocyte-colony stimulating factor. Int J Radiat Biol 86(1):12-21. 
 
Song B-L, Debose-Boyd RA. 2006. Insig-dependent ubiquitination and degradation of 3-hydroxy-3-
methylglutaryl coenzyme A reductase stimulated by δ- and γ-tocotrienols. J Biol Chem 
281(35):25054-25061. 
 
Sontag T, Parker R. 2007. Influence of major structural features of tocopherols and tocotrienols on their 
ω-oxidation by tocopherol-ω-hydroxylase.  J Lipid Res 48(5):1090-1098. 
 
Srinivasan V, Weiss JF. 1992. Radioprotection by vitamin E: injectable vitamin E administered alone or 
with WR-3689 enhances survival of irradiated mice. Int J Radiat Oncol Biol Phys 23(4):841-845. 
 
Srivastava JK, Gupta S. 2006. Tocotrienol-rich fraction of palm oil induces cell cycle arrest and apoptosis 
selectively in human prostate cancer cells. Biochem Biophys Res Comm 346:447-453. 
 
Sundl I, Murkovic M, Bandoniene D, Winklhofer-Roob BM. 2007. Vitamin E content of foods: comparison 
of results obtained from food composition tables and HPLC analysis. Clin Nutr 26:145-153. 
 
Sylvester PW, McIntyre BS, Gapor A, Briski KP. 2001. Vitamin E inhibition of normal mammary epithelial 
cell growth is associated with a reduction in protein kinase Cα activation. Cell Prolif 34:347-357. 
 
Sylvester PW, Nachnani A, Shah S, Briski KP. 2002. Role of GTP-binding proteins in reversing the 
antiproliferative effects of tocotrienols in preneoplastic mammary epithelial cells. Asia Pacific J 
Clin Nutr 11(Suppl):S452-S459. 
 
Szabó C, Ischiropoulos H, Radi R. 2007. Peroxynitrite: biochemistry, pathophysiology and development 
of therapeutics. Nature Reviews Drug Discovery 6:662-680. 
 
Takahashi K, Loo G. 2004. Disruption of mitochondria during tocotrienol-induced apoptosis in MDA-MB-
231 human breast cancer cells. Biochem Pharmacol 67:315-324. 
 
Tan B, Brzuskiewicz L. 1988. Separation of tocopherol and tocotrienol isomers using normal- and 
reverse-phase liquid chromatography. Anal Biochem 180:368-373. 
 
Teledyne Isco, Inc. n.d. Chromatography Application Note AN27. Available from: 
http://www.isco.com/WebProductFiles/Applications/101/Application_Notes/AN27_Rapid_Purificati
on_of_Tocopherols.pdf. Accessed 2013 March 1. 
 
Thai Edible Oil Group. 2005. Production. Available from: 
http://www.thaiedibleoil.com/english/product_process.php. Accessed 2011 August 16. 
 
Topping DL, Illman RJ, Roach PD, Trimble RP, Kambouris A, Nestel PJ. 1990. Modulation of the 





Traber MG, Atkinson J. 2007. Vitamin E, antioxidant and nothing more. Free Radic Biol Med 43(1):4-15. 
 
Tsuzuki W, Yunoki R, Yoshimuar H. 2007. Epithelial cells absorb γ-tocotrienol faster than α-tocopherol. 
Lipids 142(2):163-170. 
 
United States Conference on Trade and Development (UNCTAD). 2011. Rice. Available from: 
http://www.unctad.org/infocomm/anglais/rice/market.htm. Accessed 2011 August 16. 
 
United States Department of Agriculture (USDA). 2009. Rice: background. Available from: 
http://www.ers.usda.gov/Briefing/Rice/background.htm. Accessed 2011 July 22. 
 
United States Department of Agricultural Foreign Agricultural Service (USDAFAS). 2012. Global rice 
production, monthly revisions. Production, Supply, & Distribution Online Database. Available 
from: www.ers.usda.gov/briefing/rice/Data/RICETABLE%209.xls. Accessed 2012 February 6. 
 
USA Rice Federation (USARF). 2011a. All about rice. Available from: http://www.menurice.com/all-about-
rice/how-rice-is-grown/rice-anatomy. Accessed 2011 August 4. 
 
USA Rice Federation (USARF). 2011b. The U.S. rice industry at a glance. Available from: 
http://www.usarice.com/doclib/188/219/3674.PDF. Accessed 2011 July 28. 
 
van Iterson RA. 2005. A guide to validation in HPLC. Drenthe College, Emmen, Holland. Available from: 
http://www.standardbase.com/tech/HPLC%20validation%20PE.pdf. Accessed 2012 February 29. 
 
Verleyen T, Verhe R, Garcia L, Dewettinck K, Huyghebaert A, De Greht W. 2001. Gas chromatographic 
characterization of vegetable oil deodorization distillate. J Chromatography A 921:277-285. 
 
Wan J, Zhang W, Jiang B, Guo Y, Hu C. 2008. Separation of individual tocopherols from soybean 
distillate by low pressure column chromatography. J Am Oil Chem Soc 85:331-338. 
 
Wilson TA, Nicolosi R, Woolfrey B, Kritchevsky D. 2007. Rice bran oil and oryzanol reduce plasma lipid 
and lipoprotein cholesterol concentrations and aortic cholesterol ester accumulation to a greater 
extent than ferulic acid in hypercholesterolemic hamsters. J Nutr Biochem 18(2):105-112. 
 
Wright JJ, Pearce BC, Parker R, Qureshi AA, inventors. 1990. Tocotrienols in the treatment of 
hypercholesterolemia, hyperlipidemia and thromboembolic disorders. European Patent 
0421419A2. 
 
Xu Z. 2002. Analysis of tocopherols and tocotrienols. In: Wrolstad RE, editor. Current Protocols in Food 
Analytical Chemistry. New York: John Wiley & Sons. p D1.5.1-D1.5.12.  
 
Yap WN, Chang PN, Yan HY, Lee DTW, Ling MT, Wong YC, Yap YL. 2008. γ-Tocotrienol suppresses 
prostate cancer cell proliferation and invasion through multiple-signalling pathways. Brit J Canc 
99(11):1832-1841. 
 
Yoshida Y, Niki E, Noguchi N. 2003. Comparative study on the action of tocopherols and tocotrienols as 
antioxidant: chemical and physical effects. Chem Phys Lipids 123:63-75. 
 
Yoshida Y, Niki E. 2008. Antioxidant activity of tocotrienols and tocopherols in solution and membranes: 
chemical and physical effects. In: Watson RR, Preedy VR, editors. Tocotrienols: Vitamin E 
Beyond Tocopherols. Boca Raton: CRC Press. p 109-117. 
 
Yu W, Simmons-Menchaca M, Gapor A, Sanders BG, Kline K. 1999. Induction of apoptosis in human 




Zielinski H. 2008. Tocotrienols: distribution and sources cereals—role in human health. In: Watson RR, 
Preedy VR, editors. Tocotrienols: Vitamin E Beyond Tocopherols. Boca Raton: CRC Press. p 23-
42.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
